Inactivation	O
of	O
IkappaBbeta	B-protein
by	O
the	O
tax	B-protein
protein	I-protein
of	O
human	O
T-cell	O
leukemia	O
virus	O
type	O
1	O
:	O
a	O
potential	O
mechanism	O
for	O
constitutive	O
induction	O
of	O
NF-kappaB	B-protein
.	O

In	O
resting	B-cell_type
T	I-cell_type
lymphocytes	I-cell_type
,	O
the	O
transcription	B-protein
factor	I-protein
NF-kappaB	B-protein
is	O
sequestered	O
in	O
the	O
cytoplasm	O
via	O
interactions	O
with	O
members	O
of	O
the	O
I	B-protein
kappa	I-protein
B	I-protein
family	I-protein
of	O
inhibitors	O
,	O
including	O
IkappaBalpha	B-protein
and	O
IkappaBbeta	B-protein
.	O

During	O
normal	O
T-cell	O
activation	O
,	O
IkappaBalpha	B-protein
is	O
rapidly	O
phosphorylated	O
,	O
ubiquitinated	O
,	O
and	O
degraded	O
by	O
the	O
26S	B-protein
proteasome	I-protein
,	O
thus	O
permitting	O
the	O
release	O
of	O
functional	O
NF-kappaB	B-protein
.	O

In	O
contrast	O
to	O
its	O
transient	O
pattern	O
of	O
nuclear	O
induction	O
during	O
an	O
immune	O
response	O
,	O
NF-kappaB	B-protein
is	O
constitutively	O
activated	O
in	O
cells	O
expressing	O
the	O
Tax	B-protein
transforming	I-protein
protein	I-protein
of	O
human	O
T-cell	O
leukemia	O
virus	O
type	O
I	O
(	O
HTLV-1	O
)	O
.	O

Recent	O
studies	O
indicate	O
that	O
HTLV-1	O
Tax	B-protein
targets	O
IkappaBalpha	B-protein
to	O
the	O
ubiquitin-proteasome	O
pathway	O
.	O

However	O
,	O
it	O
remains	O
unclear	O
how	O
this	O
viral	B-protein
protein	I-protein
induces	O
a	O
persistent	O
rather	O
than	O
transient	O
NF-kappaB	B-protein
response	O
.	O

In	O
this	O
report	O
,	O
we	O
provide	O
evidence	O
that	O
in	O
addition	O
to	O
acting	O
on	O
IkappaBalpha	B-protein
,	O
Tax	B-protein
stimulates	O
the	O
turnover	O
Of	O
IkappaBbeta	B-protein
via	O
a	O
related	O
targeting	O
mechanism	O
.	O

Like	O
IkappaBalpha	B-protein
,	O
Tax	B-protein
-mediated	O
breakdown	O
of	O
IkappaBbeta	B-protein
in	O
transfected	B-cell_line
T	I-cell_line
lymphocytes	I-cell_line
is	O
blocked	O
either	O
by	O
cell-permeable	O
proteasome	O
inhibitors	O
or	O
by	O
mutation	O
Of	O
IkappaBbeta	B-protein
at	O
two	O
serine	O
residues	O
present	O
within	O
its	O
N-terminal	B-protein
region	I-protein
.	O

Despite	O
the	O
dual	O
specificity	O
of	O
HTLV-1	O
Tax	B-protein
for	O
IkappaBalpha	B-protein
and	O
IkappaBbeta	B-protein
at	O
the	O
protein	O
level	O
,	O
Tax	B-protein
selectively	O
stimulates	O
NF-kappaB	B-protein
-directed	O
transcription	O
of	O
the	O
IkappaBalpha	B-DNA
gene	I-DNA
.	O

Consequently	O
,	O
IkappaBbeta	B-protein
protein	O
expression	O
is	O
chronically	O
downregulated	O
in	O
HTLV-1-infected	B-cell_type
T	I-cell_type
lymphocytes	I-cell_type
.	O

These	O
findings	O
with	O
IkappaBbeta	B-protein
provide	O
a	O
potential	O
mechanism	O
for	O
the	O
constitutive	O
activation	O
of	O
NF-kappaB	B-protein
in	O
Tax-expressing	B-cell_line
cells	I-cell_line
.	O

MoLECULAR	NULL
AND	NULL
CELLULAR	NULL
BroLoGY	NULL
,	NULL
May	NULL
1996	NULL
,	NULL
p.	NULL
2083-2090	NULL
0270-7306/96/	NULL
$	NULL
04.00+0	NULL
Copyright	NULL
©	NULL
1996	NULL
,	NULL
American	NULL
Society	NULL
for	NULL
Microbiology	NULL
Vol	NULL
.	NULL

16	NULL
,	NULL
No	NULL
.	NULL

5	NULL
Inactivation	NULL
of	NULL
IxBB	NULL
by	NULL
the	NULL
Tax	NULL
Protein	NULL
of	NULL
Human	NULL
T-Cell	NULL
Leukemia	NULL
Virus	NULL
Type	NULL
1	NULL
:	NULL
a	NULL
Potential	NULL
Mechanism	NULL
for	NULL
Constitutive	NULL
Induction	NULL
of	NULL
NF-kB	NULL
TIMOTHY	NULL
A.	NULL
McKINSEY	NULL
,	NULL
*	NULL
JEFFREY	NULL
A.	NULL
BROCKMAN	NULL
,	NULL
'	NULL
DAVID	NULL
C.	NULL
SCHERER	NULL
,	NULL
``	NULL
SAMER	NULL
W.	NULL
AL-MURRANI	NULL
,	NULL
'	NULL
PATRICK	NULL
L.	NULL
GREEN	NULL
,	NULL
``	NULL
anp	NULL
DEAN	NULL
W.	NULL
BALLARD®	NULL
``	NULL
*	NULL
Howard	NULL
Hughes	NULL
Medical	NULL
Institute	NULL
``	NULL
and	NULL
Department	NULL
of	NULL
Microbiology	NULL
and	NULL
Immunology	NULL
,	NULL
``	NULL
Vanderbilt	NULL
University	NULL
School	NULL
of	NULL
Medicine	NULL
,	NULL
Nashville	NULL
,	NULL
Tennessee	NULL
Received	NULL
25	NULL
October	NULL
1995/Returned	NULL
for	NULL
modification	NULL
5	NULL
December	NULL
1995/Accepted	NULL
6	NULL
February	NULL
1996	NULL
In	NULL
resting	NULL
T	NULL
lymphocytes	NULL
,	NULL
the	NULL
transcription	NULL
factor	NULL
NF-KB	NULL
is	NULL
sequestered	NULL
in	NULL
the	NULL
cytoplasm	NULL
via	NULL
interactions	NULL
with	NULL
members	NULL
of	NULL
the	NULL
IB	NULL
family	NULL
of	NULL
inhibitors	NULL
,	NULL
including	NULL
IxBa	NULL
and	NULL
IBB	NULL
.	NULL

During	NULL
normal	NULL
T-cell	NULL
activation	NULL
,	NULL
IxBa	NULL
is	NULL
rapidly	NULL
phosphorylated	NULL
,	NULL
ubiquitinated	NULL
,	NULL
and	NULL
degraded	NULL
by	NULL
the	NULL
268	NULL
proteasome	NULL
,	NULL
thus	NULL
permitting	NULL
the	NULL
release	NULL
of	NULL
functional	NULL
NF-KB	NULL
.	NULL

In	NULL
contrast	NULL
to	NULL
its	NULL
transient	NULL
pattern	NULL
of	NULL
nuclear	NULL
induction	NULL
during	NULL
an	NULL
immune	NULL
response	NULL
,	NULL
NF-KB	NULL
is	NULL
constitutively	NULL
activated	NULL
in	NULL
cells	NULL
expressing	NULL
the	NULL
Tax	NULL
transforming	NULL
protein	NULL
of	NULL
human	NULL
T-cell	NULL
leukemia	NULL
virus	NULL
type	NULL
1	NULL
(	NULL
HTLV-1	NULL
)	NULL
.	NULL

Recent	NULL
studies	NULL
indicate	NULL
that	NULL
HTLV-1	NULL
Tax	NULL
targets	NULL
IxBa	NULL
to	NULL
the	NULL
ubiquitin-proteasome	NULL
pathway	NULL
.	NULL

However	NULL
,	NULL
it	NULL
remains	NULL
unclear	NULL
how	NULL
this	NULL
viral	NULL
protein	NULL
induces	NULL
a	NULL
persistent	NULL
rather	NULL
than	NULL
transient	NULL
NF-KB	NULL
response	NULL
.	NULL

In	NULL
this	NULL
report	NULL
,	NULL
we	NULL
provide	NULL
evidence	NULL
that	NULL
in	NULL
addition	NULL
to	NULL
acting	NULL
on	NULL
IxBa	NULL
,	NULL
Tax	NULL
stimulates	NULL
the	NULL
turnover	NULL
of	NULL
IBB	NULL
via	NULL
a	NULL
related	NULL
targeting	NULL
mechanism	NULL
.	NULL

Like	NULL
IxBa	NULL
,	NULL
Tax-mediated	NULL
breakdown	NULL
of	NULL
IBB	NULL
in	NULL
transfected	NULL
T	NULL
lymphocytes	NULL
is	NULL
blocked	NULL
either	NULL
by	NULL
cell-permeable	NULL
proteasome	NULL
inhibitors	NULL
or	NULL
by	NULL
mutation	NULL
of	NULL
IBB	NULL
at	NULL
two	NULL
serine	NULL
residues	NULL
present	NULL
within	NULL
its	NULL
N-terminal	NULL
region	NULL
.	NULL

Despite	NULL
the	NULL
dual	NULL
specificity	NULL
of	NULL
HTLV-1	NULL
Tax	NULL
for	NULL
IxBa	NULL
and	NULL
IBB	NULL
at	NULL
the	NULL
protein	NULL
level	NULL
,	NULL
Tax	NULL
selectively	NULL
stimulates	NULL
NF-KB-directed	NULL
transcription	NULL
of	NULL
the	NULL
IxBa	NULL
gene	NULL
.	NULL

Consequently	NULL
,	NULL
IBB	NULL
protein	NULL
expression	NULL
is	NULL
chronically	NULL
downregulated	NULL
in	NULL
HTLV-1-infected	NULL
T	NULL
lymphocytes	NULL
.	NULL

These	NULL
findings	NULL
with	NULL
IBB	NULL
provide	NULL
a	NULL
potential	NULL
mechanism	NULL
for	NULL
the	NULL
constitutive	NULL
activation	NULL
of	NULL
NF-KB	NULL
in	NULL
Tax-expressing	NULL
cells	NULL
.	NULL

Human	NULL
T-cell	NULL
leukemia	NULL
virus	NULL
type	NULL
1	NULL
(	NULL
HTLV-1	NULL
)	NULL
is	NULL
the	NULL
causative	NULL
agent	NULL
of	NULL
adult	NULL
T-cell	NULL
leukemia	NULL
,	NULL
an	NULL
aggressive	NULL
and	NULL
often	NULL
fatal	NULL
malignancy	NULL
of	NULL
activated	NULL
CD4*	NULL
T	NULL
lymphocytes	NULL
(	NULL
54	NULL
,	NULL
82	NULL
)	NULL
.	NULL

This	NULL
oncogenic	NULL
retrovirus	NULL
encodes	NULL
a	NULL
40-kDa	NULL
protein	NULL
,	NULL
termed	NULL
Tax	NULL
,	NULL
which	NULL
appears	NULL
to	NULL
play	NULL
a	NULL
central	NULL
role	NULL
in	NULL
the	NULL
process	NULL
of	NULL
neoplastic	NULL
transformation	NULL
(	NULL
31	NULL
,	NULL
50	NULL
,	NULL
55	NULL
,	NULL
69	NULL
,	NULL
75	NULL
)	NULL
.	NULL

In	NULL
this	NULL
regard	NULL
,	NULL
Tax	NULL
has	NULL
the	NULL
capacity	NULL
to	NULL
constitutively	NULL
activate	NULL
members	NULL
of	NULL
the	NULL
NF-	NULL
«	NULL
B/Rel	NULL
family	NULL
of	NULL
transcription	NULL
factors	NULL
(	NULL
5	NULL
,	NULL
44	NULL
,	NULL
59	NULL
)	NULL
.	NULL

This	NULL
virus-host	NULL
interplay	NULL
confers	NULL
Tax	NULL
inducibility	NULL
to	NULL
a	NULL
set	NULL
of	NULL
NF-kB-responsive	NULL
cellular	NULL
genes	NULL
that	NULL
are	NULL
normally	NULL
transcribed	NULL
at	NULL
high	NULL
levels	NULL
in	NULL
response	NULL
to	NULL
T-cell	NULL
activation	NULL
signals	NULL
.	NULL

These	NULL
genes	NULL
include	NULL
those	NULL
encoding	NULL
the	NULL
growth	NULL
factor	NULL
interleukin-2	NULL
(	NULL
IL-2	NULL
)	NULL
and	NULL
the	NULL
alpha	NULL
subunit	NULL
of	NULL
its	NULL
high-affinity	NULL
receptor	NULL
(	NULL
19	NULL
,	NULL
35	NULL
,	NULL
39	NULL
,	NULL
45	NULL
,	NULL
67	NULL
;	NULL
for	NULL
reviews	NULL
,	NULL
see	NULL
references	NULL
27	NULL
and	NULL
28	NULL
)	NULL
.	NULL

Recent	NULL
studies	NULL
with	NULL
mice	NULL
transgenic	NULL
for	NULL
the	NULL
tax	NULL
gene	NULL
suggest	NULL
that	NULL
the	NULL
constitutive	NULL
nuclear	NULL
pattern	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
expression	NULL
in	NULL
HTLV-1-infected	NULL
cells	NULL
is	NULL
required	NULL
to	NULL
maintain	NULL
a	NULL
state	NULL
of	NULL
deregulated	NULL
growth	NULL
(	NULL
40	NULL
)	NULL
.	NULL

However	NULL
,	NULL
the	NULL
precise	NULL
mechanism	NULL
by	NULL
which	NULL
Tax	NULL
induces	NULL
NF-	NULL
«	NULL
B	NULL
remains	NULL
unclear	NULL
.	NULL

The	NULL
prototypic	NULL
form	NULL
of	NULL
NF-kB	NULL
is	NULL
a	NULL
heterodimeric	NULL
complex	NULL
containing	NULL
p50	NULL
(	NULL
NF-	NULL
«	NULL
B1	NULL
)	NULL
and	NULL
RelA	NULL
(	NULL
p65	NULL
)	NULL
(	NULL
4	NULL
,	NULL
12	NULL
,	NULL
26	NULL
,	NULL
38	NULL
,	NULL
46	NULL
,	NULL
52	NULL
,	NULL
57	NULL
)	NULL
.	NULL

In	NULL
resting	NULL
T	NULL
lymphocytes	NULL
,	NULL
NF-kB	NULL
is	NULL
sequestered	NULL
in	NULL
the	NULL
cytoplasm	NULL
by	NULL
virtue	NULL
of	NULL
its	NULL
association	NULL
with	NULL
members	NULL
of	NULL
a	NULL
set	NULL
of	NULL
inhibitory	NULL
proteins	NULL
,	NULL
including	NULL
IxBa	NULL
(	NULL
2-4	NULL
,	NULL
9	NULL
,	NULL
23	NULL
)	NULL
.	NULL

During	NULL
normal	NULL
T-cell	NULL
activation	NULL
,	NULL
IxBa	NULL
is	NULL
rapidly	NULL
phosphorylated	NULL
at	NULL
Ser-32	NULL
and	NULL
Ser-36	NULL
(	NULL
13	NULL
,	NULL
14	NULL
,	NULL
78	NULL
)	NULL
,	NULL
which	NULL
is	NULL
a	NULL
prerequisite	NULL
for	NULL
targeting	NULL
this	NULL
inhibitor	NULL
to	NULL
the	NULL
ubiquitin-proteasome	NULL
pathway	NULL
(	NULL
16	NULL
,	NULL
62	NULL
;	NULL
reviewed	NULL
in	NULL
reference	NULL
22	NULL
)	NULL
.	NULL

Several	NULL
lines	NULL
of	NULL
evidence	NULL
indicate	NULL
that	NULL
*	NULL
Corresponding	NULL
author	NULL
.	NULL

Mailing	NULL
address	NULL
:	NULL
Howard	NULL
Hughes	NULL
Medical	NULL
Institute	NULL
,	NULL
Vanderbilt	NULL
University	NULL
School	NULL
of	NULL
Medicine	NULL
,	NULL
802	NULL
Rudolph	NULL
Light	NULL
Hall	NULL
,	NULL
Nashville	NULL
,	NULL
TN	NULL
37232-0295	NULL
.	NULL

Phone	NULL
:	NULL
(	NULL
615	NULL
)	NULL
343-1548	NULL
.	NULL

Fax	NULL
:	NULL
(	NULL
615	NULL
)	NULL
343-5743	NULL
.	NULL

Electronic	NULL
mail	NULL
address	NULL
:	NULL
dean.ballard	NULL
@	NULL
memail	NULL
vanderbilt.edu	NULL
.	NULL

2083	NULL
Tax	NULL
stimulates	NULL
the	NULL
phosphorylation	NULL
and	NULL
degradation	NULL
of	NULL
IxBa	NULL
via	NULL
a	NULL
similar	NULL
mechanism	NULL
.	NULL

First	NULL
,	NULL
IxBa	NULL
mutants	NULL
containing	NULL
alanine	NULL
substitutions	NULL
at	NULL
Ser-32	NULL
and	NULL
Ser-36	NULL
escape	NULL
from	NULL
proteolytic	NULL
breakdown	NULL
and	NULL
prevent	NULL
NF-kB	NULL
activation	NULL
in	NULL
Tax-expressing	NULL
cells	NULL
(	NULL
13	NULL
)	NULL
.	NULL

Second	NULL
,	NULL
Tax	NULL
fails	NULL
to	NULL
activate	NULL
latent	NULL
NF-kB	NULL
complexes	NULL
containing	NULL
mutant	NULL
forms	NULL
of	NULL
IxBa	NULL
that	NULL
are	NULL
defective	NULL
for	NULL
ubiquitination	NULL
(	NULL
62	NULL
)	NULL
.	NULL

Third	NULL
,	NULL
point	NULL
mutations	NULL
in	NULL
Tax	NULL
that	NULL
ablate	NULL
its	NULL
NF-kB-inducing	NULL
activity	NULL
also	NULL
impair	NULL
its	NULL
ability	NULL
to	NULL
stimulate	NULL
IxBa	NULL
turnover	NULL
(	NULL
13	NULL
)	NULL
.	NULL

Fourth	NULL
,	NULL
phosphorylated	NULL
IxBa	NULL
accumulates	NULL
in	NULL
Tax-expressing	NULL
cells	NULL
following	NULL
treatment	NULL
with	NULL
an	NULL
inhibitor	NULL
of	NULL
the	NULL
proteasome	NULL
(	NULL
13	NULL
)	NULL
.	NULL

Together	NULL
,	NULL
these	NULL
findings	NULL
indicate	NULL
that	NULL
cytoplasmic	NULL
NF-kB	NULL
complexes	NULL
containing	NULL
IxBa	NULL
serve	NULL
as	NULL
a	NULL
major	NULL
cellular	NULL
target	NULL
of	NULL
HTLV-1	NULL
Tax	NULL
.	NULL

Recent	NULL
molecular	NULL
cloning	NULL
studies	NULL
have	NULL
revealed	NULL
another	NULL
conditionally	NULL
labile	NULL
isoform	NULL
of	NULL
IxB	NULL
,	NULL
termed	NULL
IxBB	NULL
,	NULL
which	NULL
has	NULL
significant	NULL
sequence	NULL
homology	NULL
with	NULL
IxBa	NULL
(	NULL
77	NULL
)	NULL
.	NULL

Although	NULL
IxBa	NULL
and	NULL
IxBB	NULL
likely	NULL
interact	NULL
with	NULL
the	NULL
same	NULL
set	NULL
of	NULL
NF-kB/Re	NULL
!	NULL

l	NULL
family	NULL
members	NULL
,	NULL
it	NULL
appears	NULL
that	NULL
these	NULL
two	NULL
inhibitors	NULL
display	NULL
distinct	NULL
responses	NULL
to	NULL
different	NULL
inducers	NULL
of	NULL
NF-B	NULL
activity	NULL
(	NULL
77	NULL
)	NULL
.	NULL

As	NULL
previously	NULL
reported	NULL
(	NULL
77	NULL
)	NULL
,	NULL
agonists	NULL
that	NULL
stimulate	NULL
a	NULL
transient	NULL
pattern	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
activity	NULL
promote	NULL
the	NULL
selective	NULL
breakdown	NULL
of	NULL
IxBa	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
agents	NULL
that	NULL
elicit	NULL
a	NULL
persistent	NULL
NF-	NULL
«	NULL
B	NULL
response	NULL
,	NULL
including	NULL
bacterial	NULL
lipopolysaccharide	NULL
(	NULL
LPS	NULL
)	NULL
and	NULL
IL-1	NULL
,	NULL
are	NULL
associated	NULL
with	NULL
IxBB	NULL
inactivation	NULL
as	NULL
well	NULL
(	NULL
77	NULL
)	NULL
.	NULL

However	NULL
,	NULL
the	NULL
relationship	NULL
between	NULL
IxBB	NULL
,	NULL
Tax	NULL
,	NULL
and	NULL
the	NULL
constitutive	NULL
pattern	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
observed	NULL
in	NULL
HTLV-1-infected	NULL
T	NULL
lymphocytes	NULL
remains	NULL
undefined	NULL
.	NULL

In	NULL
this	NULL
report	NULL
,	NULL
we	NULL
identify	NULL
IBB	NULL
as	NULL
a	NULL
second	NULL
proteolytic	NULL
target	NULL
of	NULL
HTLV-1	NULL
Tax	NULL
.	NULL

As	NULL
with	NULL
IxBa	NULL
(	NULL
13	NULL
)	NULL
,	NULL
Tax	NULL
stimulates	NULL
proteasome-dependent	NULL
turnover	NULL
of	NULL
IxBB	NULL
by	NULL
a	NULL
mechanism	NULL
that	NULL
requires	NULL
the	NULL
presence	NULL
of	NULL
two	NULL
vicinal	NULL
serines	NULL
in	NULL
its	NULL
N-terminal	NULL
region	NULL
.	NULL

However	NULL
,	NULL
in	NULL
contrast	NULL
to	NULL
IxBa	NULL
,	NULL
which	NULL
is	NULL
transcriptionally	NULL
upregulated	NULL
by	NULL
Tax	NULL
,	NULL
steady-state	NULL
levels	NULL
of	NULL
the	NULL
IxBB	NULL
transcript	NULL
are	NULL
not	NULL
elevated	NULL
in	NULL
either	NULL
Tax-transfected	NULL
or	NULL
HTLV-1-infected	NULL
2084	NULL
McKINSEY	NULL
ET	NULL
AL	NULL
.	NULL

T	NULL
lymphocytes	NULL
.	NULL

Consistent	NULL
with	NULL
this	NULL
observation	NULL
,	NULL
we	NULL
show	NULL
that	NULL
the	NULL
sustained	NULL
nuclear	NULL
expression	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
in	NULL
HTLV-1-transformed	NULL
cells	NULL
is	NULL
associated	NULL
with	NULL
chronic	NULL
downregulation	NULL
of	NULL
the	NULL
IxBB	NULL
protein	NULL
.	NULL

As	NULL
such	NULL
,	NULL
the	NULL
capacity	NULL
of	NULL
Tax	NULL
to	NULL
permanently	NULL
inactivate	NULL
IxBB	NULL
may	NULL
reduce	NULL
the	NULL
concentration	NULL
of	NULL
total	NULL
intracellular	NULL
IxB	NULL
below	NULL
a	NULL
threshold	NULL
level	NULL
required	NULL
to	NULL
render	NULL
NF-kB	NULL
exclusively	NULL
cytoplasmic	NULL
.	NULL

MATERIALS	NULL
AND	NULL
METHODS	NULL
Plasmids	NULL
.	NULL

Complementary	NULL
DNAs	NULL
encoding	NULL
wild-type	NULL
and	NULL
mutant	NULL
forms	NULL
of	NULL
HTLV-1	NULL
Tax	NULL
(	NULL
68	NULL
)	NULL
,	NULL
human	NULL
IxBa	NULL
(	NULL
29	NULL
)	NULL
,	NULL
and	NULL
human	NULL
RelA	NULL
(	NULL
57	NULL
)	NULL
were	NULL
cloned	NULL
into	NULL
the	NULL
polylinker	NULL
of	NULL
the	NULL
eukaryotic	NULL
expression	NULL
vector	NULL
pCMV4	NULL
(	NULL
1	NULL
)	NULL
downstream	NULL
of	NULL
the	NULL
cytomegalovirus	NULL
immediate-early	NULL
promoter	NULL
.	NULL

A	NULL
full-length	NULL
cDNA	NULL
encoding	NULL
IBB	NULL
was	NULL
isolated	NULL
by	NULL
reverse	NULL
transcription-PCR	NULL
(	NULL
24	NULL
)	NULL
.	NULL

First-strand	NULL
DNA	NULL
was	NULL
synthesized	NULL
from	NULL
0.1	NULL
ug	NULL
of	NULL
mouse	NULL
testis	NULL
poly	NULL
(	NULL
A	NULL
)	NULL
*	NULL
RNA	NULL
(	NULL
Clontech	NULL
)	NULL
,	NULL
using	NULL
Moloney	NULL
murine	NULL
leukemia	NULL
virus	NULL
reverse	NULL
transcriptase	NULL
(	NULL
Promega	NULL
)	NULL
and	NULL
an	NULL
oligonucleotide	NULL
primer	NULL
designed	NULL
to	NULL
hybridize	NULL
to	NULL
3	NULL
'	NULL
noncoding	NULL
sequences	NULL
in	NULL
the	NULL
IxBB	NULL
transcript	NULL
(	NULL
5'-CAGGTCTGCAATTITATTAAGTTGG-3	NULL
'	NULL
)	NULL
(	NULL
77	NULL
)	NULL
.	NULL

The	NULL
reverse	NULL
transcription	NULL
product	NULL
was	NULL
amplified	NULL
by	NULL
PCR	NULL
using	NULL
specific	NULL
oligonucleotide	NULL
primers	NULL
(	NULL
5'-CCCGGTACCACCATGGCCGGGGTCGCGTGCIT-3	NULL
'	NULL
and	NULL
5-GCTCTAGA	NULL
GTCAGGCAGGGTTGGGGTCATC-3	NULL
'	NULL
)	NULL
(	NULL
77	NULL
)	NULL
.	NULL

The	NULL
amplified	NULL
cDNA	NULL
was	NULL
digested	NULL
with	NULL
KpnI	NULL
and	NULL
Xbal	NULL
,	NULL
purified	NULL
by	NULL
agarose	NULL
gel	NULL
electrophoresis	NULL
,	NULL
and	NULL
ligated	NULL
into	NULL
the	NULL
pCMV4	NULL
polylinker	NULL
.	NULL

Site-directed	NULL
mutations	NULL
were	NULL
introduced	NULL
into	NULL
the	NULL
full-length	NULL
IxBB	NULL
cDNA	NULL
by	NULL
the	NULL
phosphorothioate	NULL
method	NULL
(	NULL
49	NULL
)	NULL
and	NULL
confirmed	NULL
by	NULL
DNA	NULL
sequencing	NULL
.	NULL

Epitope-tagged	NULL
derivatives	NULL
of	NULL
IxBB	NULL
were	NULL
constructed	NULL
by	NULL
PCR	NULL
with	NULL
a	NULL
5	NULL
'	NULL
primer	NULL
that	NULL
fused	NULL
sequences	NULL
encoding	NULL
the	NULL
FLAG	NULL
epitope	NULL
(	NULL
11	NULL
,	NULL
56	NULL
)	NULL
in	NULL
frame	NULL
with	NULL
N-terminal	NULL
coding	NULL
sequences	NULL
of	NULL
IxBB	NULL
(	NULL
5'-GGGGTACCACCATGG	NULL
ACTACAAAGACGATGACGATAAAATGGCCGGGGTCGCGTGCTT-3	NULL
'	NULL
)	NULL
.	NULL

The	NULL
chloramphenicol	NULL
acetyltransferase	NULL
(	NULL
CAT	NULL
)	NULL
reporter	NULL
plasmid	NULL
contained	NULL
the	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
type	NULL
1	NULL
(	NULL
HIV-1	NULL
)	NULL
«	NULL
B	NULL
enhancer	NULL
cassette	NULL
linked	NULL
to	NULL
a	NULL
heterologous	NULL
TATA	NULL
box	NULL
(	NULL
71	NULL
)	NULL
.	NULL

Cell	NULL
culture	NULL
,	NULL
transfections	NULL
,	NULL
and	NULL
CAT	NULL
assays	NULL
.	NULL

Jurkat	NULL
leukemic	NULL
T	NULL
cells	NULL
and	NULL
the	NULL
HTLV-1-infected	NULL
T-cell	NULL
lines	NULL
Hut102	NULL
(	NULL
25	NULL
)	NULL
,	NULL
C8166	NULL
(	NULL
60	NULL
)	NULL
,	NULL
MT-2	NULL
(	NULL
48	NULL
)	NULL
,	NULL
and	NULL
MT-4	NULL
(	NULL
47	NULL
)	NULL
were	NULL
cultured	NULL
in	NULL
RPMI	NULL
1640	NULL
medium	NULL
supplemented	NULL
with	NULL
10	NULL
%	NULL
fetal	NULL
calf	NULL
serum	NULL
,	NULL
2	NULL
mM	NULL
and	NULL
antibiotics	NULL
.	NULL

The	NULL
HTLV-1-infected	NULL
T-cell	NULL
line	NULL
SLB-1	NULL
(	NULL
41	NULL
)	NULL
was	NULL
maintained	NULL
in	NULL
Iscove	NULL
's	NULL
medium	NULL
supplemented	NULL
as	NULL
described	NULL
above	NULL
.	NULL

Where	NULL
indicated	NULL
,	NULL
cell	NULL
cultures	NULL
were	NULL
treated	NULL
with	NULL
the	NULL
proteasome	NULL
inhibitor	NULL
MG132	NULL
(	NULL
100	NULL
wM	NULL
)	NULL
or	NULL
lactacystin	NULL
(	NULL
20	NULL
M	NULL
)	NULL
(	NULL
both	NULL
kindly	NULL
provided	NULL
by	NULL
ProScript	NULL
,	NULL
Inc.	NULL
)	NULL
.	NULL

In	NULL
some	NULL
experiments	NULL
,	NULL
cells	NULL
were	NULL
exposed	NULL
to	NULL
the	NULL
protein	NULL
synthesis	NULL
inhibitor	NULL
cycloheximide	NULL
(	NULL
CHX	NULL
;	NULL
50	NULL
pg/ml	NULL
;	NULL
Sigma	NULL
)	NULL
.	NULL

Transfections	NULL
were	NULL
performed	NULL
by	NULL
either	NULL
the	NULL
DEAE-dextran	NULL
method	NULL
(	NULL
34	NULL
)	NULL
or	NULL
electroporation	NULL
(	NULL
13	NULL
)	NULL
.	NULL

Input	NULL
DNA	NULL
was	NULL
normalized	NULL
for	NULL
all	NULL
transfections	NULL
by	NULL
addition	NULL
of	NULL
blank	NULL
pCMV4	NULL
vector	NULL
.	NULL

For	NULL
CAT	NULL
assays	NULL
,	NULL
whole	NULL
cell	NULL
extracts	NULL
were	NULL
prepared	NULL
and	NULL
analyzed	NULL
by	NULL
the	NULL
diffusion-based	NULL
liquid	NULL
scintillation	NULL
counting	NULL
method	NULL
(	NULL
51	NULL
)	NULL
.	NULL

Immunoprecipitation	NULL
and	NULL
immunoblotting	NULL
.	NULL

Cytosolic	NULL
extracts	NULL
were	NULL
prepared	NULL
as	NULL
previously	NULL
described	NULL
(	NULL
66	NULL
)	NULL
except	NULL
that	NULL
the	NULL
lysis	NULL
buffer	NULL
was	NULL
supplemented	NULL
with	NULL
an	NULL
extensive	NULL
cocktail	NULL
of	NULL
protease	NULL
inhibitors	NULL
(	NULL
7	NULL
)	NULL
and	NULL
phosphatase	NULL
inhibitors	NULL
(	NULL
50	NULL
mM	NULL
sodium	NULL
fluoride	NULL
,	NULL
10	NULL
mM	NULL
sodium	NULL
PP	NULL
;	NULL
,	NULL
1	NULL
wM	NULL
zinc	NULL
chloride	NULL
,	NULL
100	NULL
wM	NULL
sodium	NULL
orthovanadate	NULL
,	NULL
and	NULL
20	NULL
mM	NULL
B-glycerol	NULL
phosphate	NULL
)	NULL
.	NULL

For	NULL
purification	NULL
of	NULL
epitope-tagged	NULL
I	NULL
<	NULL
BB	NULL
,	NULL
lysates	NULL
were	NULL
equilibrated	NULL
with	NULL
ELB	NULL
buffer	NULL
(	NULL
13	NULL
)	NULL
and	NULL
fractionated	NULL
by	NULL
affinity	NULL
chromatography	NULL
with	NULL
anti-FLAG	NULL
M2	NULL
antibody	NULL
conjugated	NULL
to	NULL
agarose	NULL
beads	NULL
(	NULL
IBI-Kodak	NULL
)	NULL
.	NULL

Immunoprecipitates	NULL
were	NULL
resolved	NULL
by	NULL
sodium	NULL
dodecyl	NULL
sulfate	NULL
(	NULL
SDS	NULL
)	NULL
-polyacrylamide	NULL
gel	NULL
electrophoresis	NULL
(	NULL
PAGE	NULL
)	NULL
and	NULL
transferred	NULL
to	NULL
poly-vinylidene	NULL
difluoride	NULL
membranes	NULL
(	NULL
Dupont	NULL
)	NULL
.	NULL

Membranes	NULL
were	NULL
blocked	NULL
(	NULL
13	NULL
)	NULL
and	NULL
immunoblotted	NULL
with	NULL
a	NULL
peptide-specific	NULL
antiserum	NULL
for	NULL
either	NULL
IBB	NULL
(	NULL
Santa	NULL
Cruz	NULL
Biotechnology	NULL
;	NULL
amino	NULL
acids	NULL
330	NULL
to	NULL
359	NULL
)	NULL
,	NULL
IxBa	NULL
(	NULL
amino	NULL
acids	NULL
289	NULL
to	NULL
317	NULL
)	NULL
,	NULL
or	NULL
RelA	NULL
(	NULL
amino	NULL
acids	NULL
529	NULL
to	NULL
551	NULL
)	NULL
.	NULL

Some	NULL
immunoblotting	NULL
studies	NULL
were	NULL
performed	NULL
with	NULL
an	NULL
antiserum	NULL
prepared	NULL
against	NULL
full-length	NULL
murine	NULL
IBB	NULL
,	NULL
which	NULL
cross-reacts	NULL
with	NULL
the	NULL
human	NULL
homolog	NULL
(	NULL
77	NULL
)	NULL
(	NULL
kindly	NULL
provided	NULL
by	NULL
Sankar	NULL
Ghosh	NULL
,	NULL
Yale	NULL
University	NULL
School	NULL
of	NULL
Medicine	NULL
)	NULL
.	NULL

Immunoreactive	NULL
proteins	NULL
were	NULL
detected	NULL
by	NULL
using	NULL
anti-rabbit	NULL
im-munoglobulin	NULL
G	NULL
conjugated	NULL
to	NULL
horseradish	NULL
peroxidase	NULL
(	NULL
Amersham	NULL
)	NULL
in	NULL
conjunction	NULL
with	NULL
the	NULL
Renaissance	NULL
chemiluminescence	NULL
system	NULL
(	NULL
Dupont	NULL
)	NULL
.	NULL

Gel	NULL
retardation	NULL
assays	NULL
.	NULL

Nuclear	NULL
fractions	NULL
were	NULL
prepared	NULL
from	NULL
Jurkat	NULL
T-cell	NULL
transfectants	NULL
by	NULL
high-salt	NULL
extraction	NULL
(	NULL
66	NULL
)	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
protease	NULL
inhibitors	NULL
(	NULL
7	NULL
)	NULL
.	NULL

Gel	NULL
mobility	NULL
shift	NULL
assays	NULL
were	NULL
performed	NULL
as	NULL
previously	NULL
described	NULL
(	NULL
13	NULL
)	NULL
,	NULL
using	NULL
a	NULL
``	NULL
P-radiolabeled	NULL
palindromic	NULL
probe	NULL
derived	NULL
from	NULL
xB	NULL
enhancer	NULL
sequences	NULL
in	NULL
the	NULL
IL-2	NULL
receptor	NULL
alpha	NULL
promoter	NULL
(	NULL
5'-CAACGGCAGGGGAATTCCCCTCTCC	NULL
TT-3	NULL
'	NULL
)	NULL
(	NULL
7	NULL
)	NULL
.	NULL

Northern	NULL
(	NULL
RNA	NULL
)	NULL
blot	NULL
analyses	NULL
.	NULL

Total	NULL
RNA	NULL
was	NULL
prepared	NULL
as	NULL
previously	NULL
described	NULL
(	NULL
18	NULL
)	NULL
except	NULL
that	NULL
cells	NULL
were	NULL
lysed	NULL
in	NULL
Tris-buffered	NULL
4	NULL
M	NULL
guanidine	NULL
isothio-cyanate	NULL
(	NULL
Gibco/BRL	NULL
)	NULL
supplemented	NULL
with	NULL
10	NULL
%	NULL
Sarkosyl	NULL
.	NULL

Poly	NULL
(	NULL
A	NULL
)	NULL
*	NULL
RNA	NULL
was	NULL
purified	NULL
from	NULL
approximately	NULL
750	NULL
ug	NULL
of	NULL
total	NULL
RNA	NULL
by	NULL
using	NULL
the	NULL
polyAtract	NULL
mRNA	NULL
isolation	NULL
system	NULL
(	NULL
Promega	NULL
)	NULL
and	NULL
fractionated	NULL
by	NULL
electrophoresis	NULL
on	NULL
formaldehyde-agarose	NULL
gels	NULL
(	NULL
18	NULL
)	NULL
.	NULL

Following	NULL
electrophoresis	NULL
,	NULL
RNA	NULL
was	NULL
transferred	NULL
to	NULL
Zeta	NULL
Probe	NULL
membranes	NULL
(	NULL
Bio-Rad	NULL
)	NULL
and	NULL
sequentially	NULL
hybridized	NULL
with	NULL
the	NULL
indicated	NULL
*°P-radiolabeled	NULL
cDNA	NULL
probes	NULL
at	NULL
42°C	NULL
in	NULL
a	NULL
solution	NULL
containing	NULL
50	NULL
%	NULL
formamide	NULL
,	NULL
5	NULL
%	NULL
SSC	NULL
(	NULL
1	NULL
%	NULL
SSC	NULL
is	NULL
0.15	NULL
M	NULL
NaCl	NULL
plus	NULL
0.015	NULL
sodium	NULL
citrate	NULL
)	NULL
,	NULL
1X	NULL
Denhardt	NULL
's	NULL
reagent	NULL
,	NULL
1	NULL
%	NULL
SDS	NULL
,	NULL
and	NULL
0.1	NULL
mg	NULL
of	NULL
salmon	NULL
testis	NULL
DNA	NULL
(	NULL
Sigma	NULL
)	NULL
per	NULL
ml	NULL
.	NULL

Radiola-beled	NULL
probes	NULL
were	NULL
generated	NULL
by	NULL
using	NULL
a	NULL
Random	NULL
Primed	NULL
DNA	NULL
Labeling	NULL
kit	NULL
(	NULL
Boehringer	NULL
Mannheim	NULL
)	NULL
.	NULL

Mor	NULL
.	NULL

CELL	NULL
.	NULL

BioL	NULL
.	NULL

A	NULL
B	NULL
IkBa	NULL
IBB	NULL
{	NULL
1	NULL
2	NULL
s	NULL
4	NULL
}	NULL
5	NULL
6	NULL
7	NULL
8	NULL
%	NULL
Inhibition	NULL
0	NULL
25	NULL
5	NULL
10	NULL
0	NULL
25	NULL
5	NULL
10	NULL
Effector	NULL
plasmid	NULL
(	NULL
ug	NULL
)	NULL
01	NULL
O2	NULL
03	NULL
04	NULL
05	NULL
Effector	NULL
plasmid	NULL
(	NULL
ug	NULL
)	NULL
FIG	NULL
.	NULL

1	NULL
.	NULL

IxBB	NULL
inhibits	NULL
NF-xB	NULL
activity	NULL
in	NULL
T	NULL
lymphocytes	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Repression	NULL
of	NULL
NF-	NULL
«	NULL
B-dependent	NULL
transcription	NULL
.	NULL

Human	NULL
Jurkat	NULL
T	NULL
cells	NULL
were	NULL
transfected	NULL
by	NULL
using	NULL
DEAE-dextran	NULL
with	NULL
a	NULL
pCMV4-based	NULL
RelA	NULL
expression	NULL
vector	NULL
(	NULL
2	NULL
ug	NULL
)	NULL
,	NULL
graded	NULL
amounts	NULL
of	NULL
the	NULL
indicated	NULL
IB	NULL
construct	NULL
,	NULL
and	NULL
HIV-	NULL
«	NULL
B-CAT	NULL
(	NULL
2	NULL
pg	NULL
)	NULL
.	NULL

After	NULL
48	NULL
h	NULL
in	NULL
culture	NULL
,	NULL
whole	NULL
cell	NULL
extracts	NULL
were	NULL
prepared	NULL
,	NULL
normalized	NULL
for	NULL
total	NULL
protein	NULL
,	NULL
and	NULL
assayed	NULL
for	NULL
CAT	NULL
activity	NULL
.	NULL

Results	NULL
from	NULL
three	NULL
independent	NULL
transfections	NULL
are	NULL
reported	NULL
as	NULL
the	NULL
mean	NULL
percent	NULL
inhibition	NULL
(	NULL
+	NULL
standard	NULL
error	NULL
of	NULL
the	NULL
mean	NULL
)	NULL
of	NULL
CAT	NULL
activity	NULL
in	NULL
cells	NULL
expressing	NULL
IxB	NULL
effector	NULL
versus	NULL
those	NULL
expressing	NULL
RelA	NULL
alone	NULL
(	NULL
fold	NULL
induction	NULL
=	NULL
27.3	NULL
+	NULL
2.4	NULL
)	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Inhibition	NULL
of	NULL
nuclear	NULL
NF-	NULL
«	NULL
B/ReIA	NULL
DNA	NULL
binding	NULL
.	NULL

Jurkat	NULL
T	NULL
cells	NULL
were	NULL
transfected	NULL
by	NULL
electroporation	NULL
with	NULL
an	NULL
expression	NULL
vector	NULL
encoding	NULL
RelA	NULL
(	NULL
10	NULL
mg	NULL
)	NULL
and	NULL
graded	NULL
doses	NULL
of	NULL
the	NULL
indicated	NULL
IxB	NULL
construct	NULL
.	NULL

Approximately	NULL
48	NULL
h	NULL
after	NULL
transfection	NULL
,	NULL
cultures	NULL
were	NULL
treated	NULL
with	NULL
CHX	NULL
(	NULL
50	NULL
pg/ml	NULL
)	NULL
for	NULL
2	NULL
h.	NULL
Nuclear	NULL
protein	NULL
extracts	NULL
(	NULL
5	NULL
ug	NULL
)	NULL
were	NULL
added	NULL
to	NULL
DNA	NULL
binding	NULL
reaction	NULL
mixtures	NULL
containing	NULL
a	NULL
*°P-labeled	NULL
palindromic	NULL
«	NULL
B	NULL
probe	NULL
and	NULL
analyzed	NULL
on	NULL
a	NULL
5	NULL
%	NULL
native	NULL
polyacrylamide	NULL
gel	NULL
.	NULL

Nucleoprotein	NULL
complexes	NULL
containing	NULL
RelA	NULL
homodimers	NULL
(	NULL
upper	NULL
arrow	NULL
)	NULL
and	NULL
RelA/p50	NULL
heterodimers	NULL
(	NULL
lower	NULL
arrow	NULL
)	NULL
are	NULL
indicated	NULL
.	NULL

RESULTS	NULL
IBB	NULL
regulates	NULL
NF-KB	NULL
function	NULL
in	NULL
human	NULL
T	NULL
lymphocytes	NULL
.	NULL

Constitutive	NULL
nuclear	NULL
expression	NULL
of	NULL
NF-kB	NULL
in	NULL
HTLV-1	NULL
Tax-expressing	NULL
cells	NULL
is	NULL
associated	NULL
with	NULL
proteolytic	NULL
inactivation	NULL
of	NULL
IxBa	NULL
by	NULL
the	NULL
268	NULL
proteasome	NULL
(	NULL
13	NULL
,	NULL
62	NULL
)	NULL
.	NULL

To	NULL
establish	NULL
an	NULL
in	NULL
vivo	NULL
assay	NULL
for	NULL
examining	NULL
whether	NULL
Tax	NULL
alters	NULL
the	NULL
stability	NULL
of	NULL
IxBB	NULL
,	NULL
we	NULL
first	NULL
compared	NULL
the	NULL
capacities	NULL
of	NULL
ectopic	NULL
IxBa	NULL
and	NULL
IxBB	NULL
to	NULL
inhibit	NULL
NF-	NULL
«	NULL
B-dependent	NULL
transcription	NULL
in	NULL
T-cell	NULL
transfectants	NULL
.	NULL

Jurkat	NULL
T	NULL
lymphocytes	NULL
were	NULL
cotransfected	NULL
with	NULL
a	NULL
CAT	NULL
reporter	NULL
plasmid	NULL
containing	NULL
two	NULL
NF-	NULL
«	NULL
B	NULL
binding	NULL
sites	NULL
from	NULL
the	NULL
HIV-1	NULL
enhancer	NULL
(	NULL
HIV-kB-CAT	NULL
)	NULL
,	NULL
an	NULL
effector	NULL
plasmid	NULL
encoding	NULL
the	NULL
RelA	NULL
transactivating	NULL
subunit	NULL
of	NULL
NF-kB	NULL
,	NULL
and	NULL
graded	NULL
amounts	NULL
of	NULL
expression	NULL
vectors	NULL
for	NULL
either	NULL
IxBa	NULL
or	NULL
IxBB	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

1A	NULL
,	NULL
both	NULL
IxBa	NULL
and	NULL
IxBB	NULL
inhibited	NULL
RelA-dependent	NULL
transcription	NULL
of	NULL
the	NULL
CAT	NULL
reporter	NULL
gene	NULL
in	NULL
a	NULL
dose-dependent	NULL
manner	NULL
.	NULL

In	NULL
keeping	NULL
with	NULL
these	NULL
functional	NULL
results	NULL
,	NULL
gel	NULL
retardation	NULL
assays	NULL
performed	NULL
with	NULL
nuclear	NULL
extracts	NULL
from	NULL
RelA-expressing	NULL
transfectants	NULL
indicated	NULL
that	NULL
both	NULL
IxBa	NULL
and	NULL
IxBB	NULL
efficiently	NULL
blocked	NULL
the	NULL
DNA	NULL
binding	NULL
activity	NULL
of	NULL
RelA	NULL
homodimers	NULL
(	NULL
Fig	NULL
.	NULL

1B	NULL
;	NULL
upper	NULL
complex	NULL
)	NULL
.	NULL

These	NULL
inhibitors	NULL
also	NULL
sequestered	NULL
the	NULL
kB-specific	NULL
activity	NULL
of	NULL
NF-kB	NULL
(	NULL
lower	NULL
complex	NULL
)	NULL
,	NULL
which	NULL
is	NULL
generated	NULL
as	NULL
a	NULL
consequence	NULL
of	NULL
RelA-mediated	NULL
transactivation	NULL
of	NULL
the	NULL
NF-	NULL
«	NULL
B1	NULL
gene	NULL
encoding	NULL
the	NULL
p50	NULL
subunit	NULL
(	NULL
76	NULL
)	NULL
.	NULL

HTLV-1	NULL
Tax	NULL
renders	NULL
IBB	NULL
susceptible	NULL
to	NULL
proteasome-dependent	NULL
degradation	NULL
.	NULL

Having	NULL
established	NULL
that	NULL
ectopic	NULL
IxBB	NULL
inhibits	NULL
NF-xB	NULL
in	NULL
transfected	NULL
human	NULL
T	NULL
cells	NULL
,	NULL
we	NULL
next	NULL
compared	NULL
the	NULL
stabilities	NULL
of	NULL
IxBB	NULL
and	NULL
IxBa	NULL
when	NULL
independently	NULL
coexpressed	NULL
with	NULL
HTLV-1	NULL
Tax	NULL
.	NULL

Jurkat	NULL
T	NULL
cells	NULL
were	NULL
cotransfected	NULL
with	NULL
pCMV4	NULL
expression	NULL
vectors	NULL
(	NULL
1	NULL
)	NULL
encoding	NULL
FLAG	NULL
epitope-tagged	NULL
forms	NULL
of	NULL
these	NULL
inhibitors	NULL
and	NULL
wild-type	NULL
Tax	NULL
.	NULL

Transfected	NULL
cells	NULL
were	NULL
exposed	NULL
to	NULL
CHX	NULL
in	NULL
order	NULL
to	NULL
prevent	NULL
de	NULL
novo	NULL
protein	NULL
synthesis	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

2A	NULL
,	NULL
coexpression	NULL
with	NULL
Tax	NULL
led	NULL
to	NULL
a	NULL
significant	NULL
reduction	NULL
in	NULL
the	NULL
cytoplasmic	NULL
levels	NULL
of	NULL
both	NULL
IxBa	NULL
and	NULL
IxBfB	NULL
relative	NULL
to	NULL
that	NULL
observed	NULL
in	NULL
Tax-deficient	NULL
con-trols	NULL
.	NULL

These	NULL
studies	NULL
also	NULL
suggested	NULL
that	NULL
IxBB	NULL
and	NULL
IxBa	NULL
are	NULL
Vou	NULL
.	NULL

16	NULL
,	NULL
1996	NULL
DEREGULATION	NULL
OF	NULL
IkBB	NULL
BY	NULL
HTLV-1	NULL
Tax	NULL
2085	NULL
IBB	NULL
|	NULL
memes	NULL
cee	NULL
cen	NULL
.	NULL

sence	NULL
an	NULL
ome	NULL
Tax	NULL
+	NULL
ees	NULL
cave	NULL
CHX	NULL
T	NULL
I	NULL
I	NULL
I	NULL
I	NULL
I	NULL
I	NULL
|	NULL
I	NULL
I	NULL
I	NULL
0	NULL
-	NULL
0.5	NULL
1.0	NULL
20	NULL
4.0	NULL
0	NULL
-	NULL
0.5	NULL
1.0	NULL
20	NULL
4.0	NULL
TIME	NULL
(	NULL
HOURS	NULL
)	NULL
C	NULL
I	NULL
I	NULL
I	NULL
I	NULL
IkBB-	NULL
s	NULL
x=	NULL
kBB-Nau	NULL
Ny	NULL
Na	NULL
N	NULL
A	NULL
CA	NULL
C3	NULL
.	NULL

z	NULL
~	NULL
G	NULL
S	NULL
MG132	NULL
:	NULL
~	NULL
_	NULL
1	NULL
2	NULL
3	NULL
1	NULL
2	NULL
3	NULL
I	NULL
I	NULL
I	NULL
1	NULL
1	NULL
I	NULL
IkBB	NULL
-	NULL
-	NULL
Whew	NULL
ass	NULL
To	NULL
_	NULL
t	NULL
-+	NULL
Tax	NULL
:	NULL
-o	NULL
$	NULL
4	NULL
+	NULL
Lactacystin	NULL
:	NULL
_-	NULL
-	NULL
4	NULL
FIG	NULL
.	NULL

2	NULL
.	NULL

HTLV-1	NULL
Tax	NULL
stimulates	NULL
proteasome-dependent	NULL
degradation	NULL
of	NULL
IBB	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Jurkat	NULL
T	NULL
cells	NULL
were	NULL
cotransfected	NULL
by	NULL
electroporation	NULL
with	NULL
expression	NULL
vectors	NULL
encoding	NULL
Tax	NULL
(	NULL
10	NULL
ug	NULL
)	NULL
and	NULL
either	NULL
FLAG-tagged	NULL
IxBa	NULL
(	NULL
2	NULL
ug	NULL
)	NULL
or	NULL
IxBB	NULL
(	NULL
0.5	NULL
mg	NULL
)	NULL
.	NULL

Total	NULL
DNA	NULL
input	NULL
was	NULL
normalized	NULL
by	NULL
using	NULL
the	NULL
pCMV4	NULL
vector	NULL
.	NULL

Cytoplasmic	NULL
extracts	NULL
were	NULL
prepared	NULL
from	NULL
transfected	NULL
cells	NULL
after	NULL
treatment	NULL
with	NULL
CHX	NULL
for	NULL
the	NULL
indicated	NULL
times	NULL
.	NULL

Ectopic	NULL
forms	NULL
of	NULL
IxB	NULL
were	NULL
isolated	NULL
by	NULL
immunoprecipitation	NULL
with	NULL
anti-FLAG	NULL
antibodies	NULL
,	NULL
resolved	NULL
by	NULL
SDS-PAGE	NULL
,	NULL
and	NULL
immunoblotted	NULL
with	NULL
either	NULL
IxBa-	NULL
or	NULL
I	NULL
<	NULL
BB-specific	NULL
antiserum	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Jurkat	NULL
cells	NULL
were	NULL
cotransfected	NULL
with	NULL
expression	NULL
vectors	NULL
encoding	NULL
FLAG-tagged	NULL
IxB	NULL
$	NULL
B	NULL
(	NULL
1	NULL
ug	NULL
)	NULL
and	NULL
either	NULL
wild-type	NULL
Tax	NULL
(	NULL
Tax-WT	NULL
)	NULL
(	NULL
10	NULL
g	NULL
)	NULL
or	NULL
a	NULL
mutant	NULL
of	NULL
Tax	NULL
defective	NULL
in	NULL
NF-	NULL
«	NULL
B	NULL
(	NULL
Tax-M22	NULL
)	NULL
or	NULL
CREB/ATF	NULL
(	NULL
Tax-M47	NULL
)	NULL
activating	NULL
function	NULL
(	NULL
10	NULL
pg	NULL
)	NULL
.	NULL

After	NULL
48	NULL
h	NULL
in	NULL
culture	NULL
,	NULL
cells	NULL
were	NULL
treated	NULL
with	NULL
CHX	NULL
for	NULL
6	NULL
h.	NULL
Cytoplasmic	NULL
extracts	NULL
were	NULL
fractionated	NULL
as	NULL
described	NULL
above	NULL
and	NULL
immunoblotted	NULL
with	NULL
IxBB-specific	NULL
antiserum	NULL
.	NULL

(	NULL
C	NULL
and	NULL
D	NULL
)	NULL
Jurkat	NULL
T	NULL
cells	NULL
were	NULL
transfected	NULL
by	NULL
electroporation	NULL
with	NULL
a	NULL
plasmid	NULL
encoding	NULL
FLAG-tagged	NULL
I	NULL
«	NULL
BB	NULL
(	NULL
1	NULL
g	NULL
)	NULL
in	NULL
the	NULL
absence	NULL
or	NULL
presence	NULL
of	NULL
a	NULL
Tax	NULL
expression	NULL
vector	NULL
(	NULL
10	NULL
pg	NULL
)	NULL
.	NULL

After	NULL
48	NULL
h	NULL
of	NULL
culture	NULL
,	NULL
cells	NULL
were	NULL
treated	NULL
with	NULL
CHX	NULL
for	NULL
1	NULL
h	NULL
and	NULL
then	NULL
exposed	NULL
to	NULL
the	NULL
proteasome	NULL
inhibitor	NULL
MG132	NULL
(	NULL
100	NULL
wM	NULL
)	NULL
or	NULL
lactacystin	NULL
(	NULL
20	NULL
wM	NULL
)	NULL
for	NULL
6	NULL
h.	NULL
Cytoplasmic	NULL
extracts	NULL
were	NULL
fractionated	NULL
and	NULL
immunoblotted	NULL
with	NULL
an	NULL
IxBB-specific	NULL
antiserum	NULL
as	NULL
described	NULL
above	NULL
.	NULL

degraded	NULL
with	NULL
distinct	NULL
kinetics	NULL
in	NULL
Tax-expressing	NULL
cells	NULL
.	NULL

To	NULL
provide	NULL
stringent	NULL
controls	NULL
for	NULL
these	NULL
experiments	NULL
,	NULL
we	NULL
also	NULL
used	NULL
vectors	NULL
for	NULL
Tax	NULL
containing	NULL
missense	NULL
mutations	NULL
that	NULL
selectively	NULL
disrupt	NULL
its	NULL
ability	NULL
to	NULL
access	NULL
either	NULL
the	NULL
CREB/ATF	NULL
(	NULL
Tax-M47	NULL
)	NULL
or	NULL
NF-kB/Rel	NULL
(	NULL
Tax-M22	NULL
)	NULL
transcription	NULL
factor	NULL
pathway	NULL
(	NULL
68	NULL
)	NULL
.	NULL

The	NULL
steady-state	NULL
level	NULL
of	NULL
ectopic	NULL
IxBB	NULL
was	NULL
substantially	NULL
reduced	NULL
in	NULL
control	NULL
cells	NULL
expressing	NULL
wild-type	NULL
Tax	NULL
(	NULL
Tax-WT	NULL
)	NULL
(	NULL
Fig	NULL
.	NULL

2B	NULL
,	NULL
lane	NULL
2	NULL
)	NULL
.	NULL

Consistent	NULL
with	NULL
their	NULL
differing	NULL
capacities	NULL
to	NULL
induce	NULL
NF-kB	NULL
,	NULL
expression	NULL
of	NULL
Tax-M47	NULL
but	NULL
not	NULL
Tax-M22	NULL
resulted	NULL
in	NULL
the	NULL
degradative	NULL
loss	NULL
of	NULL
IxBB	NULL
(	NULL
lanes	NULL
3	NULL
and	NULL
4	NULL
)	NULL
.	NULL

These	NULL
findings	NULL
correlate	NULL
the	NULL
NF-	NULL
function	NULL
of	NULL
Tax	NULL
with	NULL
its	NULL
ability	NULL
to	NULL
destabilize	NULL
IxBB	NULL
in	NULL
transfected	NULL
T	NULL
cells	NULL
.	NULL

Recent	NULL
studies	NULL
suggest	NULL
that	NULL
the	NULL
constitutive	NULL
turnover	NULL
of	NULL
IxBa	NULL
in	NULL
cells	NULL
expressing	NULL
Tax	NULL
is	NULL
mediated	NULL
by	NULL
the	NULL
ubiquitin-proteasome	NULL
pathway	NULL
(	NULL
13	NULL
,	NULL
62	NULL
)	NULL
.	NULL

To	NULL
examine	NULL
whether	NULL
Tax	NULL
also	NULL
targets	NULL
IxBB	NULL
to	NULL
the	NULL
proteasome	NULL
,	NULL
we	NULL
assessed	NULL
the	NULL
ability	NULL
of	NULL
the	NULL
previously	NULL
described	NULL
proteasome	NULL
inhibitors	NULL
MG132	NULL
(	NULL
53	NULL
)	NULL
and	NULL
lactacystin	NULL
(	NULL
21	NULL
)	NULL
to	NULL
block	NULL
Tax-induced	NULL
turnover	NULL
of	NULL
IxBB	NULL
in	NULL
Jurkat	NULL
T-cell	NULL
transfectants	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

2C	NULL
,	NULL
ectopic	NULL
IxBB	NULL
was	NULL
efficiently	NULL
degraded	NULL
in	NULL
control	NULL
cells	NULL
(	NULL
lane	NULL
2	NULL
)	NULL
but	NULL
escaped	NULL
from	NULL
Tax-dependent	NULL
breakdown	NULL
in	NULL
cells	NULL
treated	NULL
with	NULL
MG132	NULL
(	NULL
lane	NULL
3	NULL
)	NULL
.	NULL

Similar	NULL
results	NULL
were	NULL
obtained	NULL
with	NULL
lactacystin	NULL
,	NULL
a	NULL
highly	NULL
specific	NULL
inhibitor	NULL
of	NULL
the	NULL
proteasome	NULL
(	NULL
Fig	NULL
.	NULL

2D	NULL
)	NULL
.	NULL

Coupled	NULL
with	NULL
the	NULL
data	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

2A	NULL
and	NULL
B	NULL
,	NULL
these	NULL
transfection	NULL
studies	NULL
impli-	NULL
cate	NULL
the	NULL
proteasome	NULL
degradation	NULL
pathway	NULL
in	NULL
the	NULL
mechanism	NULL
by	NULL
which	NULL
Tax	NULL
inactivates	NULL
IBB	NULL
.	NULL

Identification	NULL
of	NULL
two	NULL
regulatory	NULL
serines	NULL
in	NULL
the	NULL
N	NULL
terminus	NULL
of	NULL
IBB	NULL
.	NULL

IxBa	NULL
contains	NULL
two	NULL
highly	NULL
conserved	NULL
serine	NULL
residues	NULL
at	NULL
positions	NULL
32	NULL
and	NULL
36	NULL
which	NULL
are	NULL
required	NULL
for	NULL
its	NULL
signal-dependent	NULL
phosphorylation	NULL
(	NULL
13	NULL
,	NULL
14	NULL
,	NULL
78	NULL
)	NULL
,	NULL
ubiquitination	NULL
(	NULL
16	NULL
,	NULL
62	NULL
)	NULL
,	NULL
and	NULL
degradation	NULL
(	NULL
13	NULL
,	NULL
14	NULL
,	NULL
16	NULL
,	NULL
78	NULL
)	NULL
.	NULL

Disruption	NULL
of	NULL
either	NULL
Ser-32	NULL
or	NULL
Ser-36	NULL
in	NULL
IxBa	NULL
yields	NULL
a	NULL
constitutive	NULL
NF-kB	NULL
inhibitor	NULL
that	NULL
remains	NULL
stable	NULL
despite	NULL
the	NULL
presence	NULL
of	NULL
HTLV-1	NULL
Tax	NULL
(	NULL
13	NULL
)	NULL
.	NULL

Inspection	NULL
of	NULL
the	NULL
deduced	NULL
N-terminal	NULL
sequence	NULL
of	NULL
IxBB	NULL
(	NULL
77	NULL
)	NULL
revealed	NULL
a	NULL
motif	NULL
containing	NULL
two	NULL
serines	NULL
(	NULL
Asp-Ser-Gly-Leu-Gly-Ser-Leu	NULL
;	NULL
amino	NULL
acids	NULL
18	NULL
to	NULL
24	NULL
)	NULL
that	NULL
is	NULL
strikingly	NULL
similar	NULL
to	NULL
that	NULL
found	NULL
in	NULL
IxBa	NULL
(	NULL
Asp-Ser-Gly-Leu-Asp-Ser-Met	NULL
;	NULL
amino	NULL
acids	NULL
31	NULL
to	NULL
37	NULL
)	NULL
(	NULL
29	NULL
)	NULL
.	NULL

To	NULL
explore	NULL
whether	NULL
Ser-19	NULL
and	NULL
Ser-23	NULL
of	NULL
IxBB	NULL
are	NULL
required	NULL
for	NULL
inactivation	NULL
by	NULL
Tax	NULL
,	NULL
a	NULL
series	NULL
of	NULL
specific	NULL
amino	NULL
acid	NULL
substitutions	NULL
was	NULL
introduced	NULL
into	NULL
the	NULL
full-length	NULL
inhibitor	NULL
.	NULL

All	NULL
of	NULL
the	NULL
corresponding	NULL
mutant	NULL
proteins	NULL
were	NULL
expressed	NULL
at	NULL
comparable	NULL
levels	NULL
in	NULL
vivo	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

As	NULL
illustrated	NULL
in	NULL
Fig	NULL
.	NULL

3A	NULL
,	NULL
substitution	NULL
of	NULL
alanine	NULL
for	NULL
either	NULL
Ser-19	NULL
or	NULL
Ser-23	NULL
in	NULL
ectopic	NULL
IxBB	NULL
(	NULL
mutants	NULL
$	NULL
19A	NULL
and	NULL
$	NULL
23A	NULL
)	NULL
markedly	NULL
attenuated	NULL
Tax-mediated	NULL
transactivation	NULL
of	NULL
HIV-	NULL
«	NULL
kB-CAT	NULL
in	NULL
Jurkat	NULL
T-cell	NULL
transfectants	NULL
.	NULL

Similar	NULL
results	NULL
were	NULL
obtained	NULL
with	NULL
an	NULL
IBB	NULL
mutant	NULL
containing	NULL
simultaneous	NULL
Ser-	NULL
>	NULL
Ala	NULL
substitutions	NULL
at	NULL
these	NULL
positions	NULL
(	NULL
mutant	NULL
$	NULL
19/23A	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
IxBB	NULL
constructs	NULL
con	NULL
2086	NULL
McKINSEY	NULL
ET	NULL
AL	NULL
.	NULL

__	NULL
Anti-RelA	NULL
2	NULL
2	NULL
s	NULL
I	NULL
4	NULL
5	NULL
is	NULL
-	NULL
100	NULL
Pod	NULL
ob	NULL
dub	NULL
a	NULL
&	NULL
|	NULL
<	NULL
—	NULL
(	NULL
75	NULL
68	NULL
-	NULL
mals	NULL
55	NULL
m	NULL
._	NULL
$	NULL
=	NULL
so	NULL
a	NULL
a1-g	NULL
25	NULL
°	NULL
é	NULL
?	NULL

4	NULL
8	NULL
&	NULL
8	NULL
&	NULL
A4	NULL
4	NULL
kok/g	NULL
\	NULL
kg	NULL
;	NULL
o	NULL
s	NULL
&	NULL
4	NULL
n	NULL
¢	NULL
,	NULL
.	NULL

d	NULL
o	NULL
4	NULL
%	NULL
*~	NULL
,	NULL
4	NULL
%	NULL
a	NULL
``	NULL
5	NULL
&	NULL
,	NULL
0	NULL
.	NULL

4	NULL
,	NULL
th	NULL
4	NULL
4	NULL
a	NULL
.	NULL

4	NULL
%	NULL
'	NULL
o	NULL
.	NULL

¥	NULL
%	NULL
%	NULL
90747	NULL
7	NULL
z	NULL
<	NULL
3	NULL
;	NULL
&	NULL
*	NULL
%	NULL
,	NULL
WT	NULL
__	NULL
$	NULL
19/23A	NULL
pCMV4	NULL
WT	NULL
$	NULL
19/23A	NULL
10	NULL
2	NULL
I	NULL
s	NULL
4	NULL
1	NULL
2	NULL
:	NULL
?	NULL

1	NULL
a	NULL
?	NULL

ti	NULL
?	NULL

I	NULL
1	NULL
I	NULL
I	NULL
1	NULL
t	NULL
ca	NULL
--	NULL
>	NULL
<	NULL
G	NULL
A	NULL
46-~	NULL
~~	NULL
*	NULL
>	NULL
-	NULL
«	NULL
Wits	NULL
t	NULL
ﬁ	NULL
at-Tak	NULL
-	NULL
40	NULL
-	NULL
+	NULL
Tac	NULL
-	NULL
+	NULL
-o	NULL
+	NULL
-	NULL
0+	NULL
FIG	NULL
.	NULL

3	NULL
.	NULL

Serine	NULL
residues	NULL
19	NULL
and	NULL
23	NULL
of	NULL
IxBB	NULL
are	NULL
required	NULL
for	NULL
inactivation	NULL
by	NULL
Tax	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Induction	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
transcriptional	NULL
activity	NULL
.	NULL

Jurkat	NULL
T	NULL
cells	NULL
were	NULL
transfected	NULL
by	NULL
electroporation	NULL
with	NULL
HIV-	NULL
«	NULL
kB-CAT	NULL
(	NULL
5	NULL
pg	NULL
)	NULL
along	NULL
with	NULL
cDNA	NULL
expression	NULL
vectors	NULL
encoding	NULL
Tax	NULL
(	NULL
5	NULL
ug	NULL
)	NULL
and	NULL
the	NULL
indicated	NULL
site-directed	NULL
mutants	NULL
of	NULL
IxBB	NULL
(	NULL
2.5	NULL
ug	NULL
)	NULL
.	NULL

After	NULL
48	NULL
h	NULL
of	NULL
growth	NULL
,	NULL
cells	NULL
were	NULL
harvested	NULL
and	NULL
assayed	NULL
for	NULL
CAT	NULL
activity	NULL
.	NULL

Tax-dependent	NULL
increases	NULL
in	NULL
reporter	NULL
gene	NULL
activity	NULL
are	NULL
expressed	NULL
as	NULL
a	NULL
percentage	NULL
of	NULL
the	NULL
activity	NULL
induced	NULL
in	NULL
cells	NULL
transfected	NULL
with	NULL
wild-type	NULL
IxBB	NULL
(	NULL
WT	NULL
;	NULL
fold	NULL
induction	NULL
=	NULL
32.5	NULL
+	NULL
3.4	NULL
)	NULL
.	NULL

Each	NULL
bar	NULL
represents	NULL
the	NULL
mean	NULL
+	NULL
standard	NULL
error	NULL
of	NULL
the	NULL
mean	NULL
from	NULL
three	NULL
independent	NULL
experiments	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Association	NULL
with	NULL
endogenous	NULL
RelA	NULL
.	NULL

Jurkat	NULL
T	NULL
cells	NULL
were	NULL
transfected	NULL
by	NULL
electroporation	NULL
with	NULL
expression	NULL
vectors	NULL
encoding	NULL
the	NULL
indicated	NULL
FLAG-tagged	NULL
derivatives	NULL
of	NULL
IxBB	NULL
(	NULL
20	NULL
ug	NULL
)	NULL
or	NULL
with	NULL
unmodified	NULL
pCMV4	NULL
vector	NULL
(	NULL
20	NULL
mg	NULL
)	NULL
.	NULL

Cytoplasmic	NULL
complexes	NULL
containing	NULL
ectopic	NULL
IxBB	NULL
were	NULL
isolated	NULL
by	NULL
immunoaffinity	NULL
chromatography	NULL
,	NULL
fractionated	NULL
by	NULL
SDS-PAGE	NULL
,	NULL
and	NULL
analyzed	NULL
by	NULL
immunoblotting	NULL
with	NULL
the	NULL
indicated	NULL
antisera	NULL
.	NULL

Molecular	NULL
sizes	NULL
are	NULL
given	NULL
in	NULL
kilodaltons	NULL
.	NULL

(	NULL
C	NULL
)	NULL
Steady-state	NULL
levels	NULL
of	NULL
IxBB	NULL
protein	NULL
.	NULL

Jurkat	NULL
T	NULL
cells	NULL
were	NULL
transfected	NULL
by	NULL
electroporation	NULL
with	NULL
expression	NULL
plasmids	NULL
encoding	NULL
FLAG-tagged	NULL
wild-type	NULL
IxBB	NULL
(	NULL
WT	NULL
;	NULL
1	NULL
mg	NULL
)	NULL
or	NULL
mutant	NULL
$	NULL
19/23A	NULL
(	NULL
1	NULL
pg	NULL
)	NULL
in	NULL
the	NULL
absence	NULL
or	NULL
presence	NULL
of	NULL
Tax-WT	NULL
(	NULL
10	NULL
pg	NULL
)	NULL
.	NULL

After	NULL
48	NULL
h	NULL
in	NULL
culture	NULL
,	NULL
cells	NULL
were	NULL
treated	NULL
with	NULL
CHX	NULL
for	NULL
6	NULL
h.	NULL
Cytoplasmic	NULL
extracts	NULL
were	NULL
prepared	NULL
,	NULL
immunoprecipitated	NULL
with	NULL
anti-FLAG	NULL
anti-body	NULL
,	NULL
and	NULL
immunoblotted	NULL
with	NULL
IxBB-specific	NULL
antiserum	NULL
.	NULL

Sizes	NULL
are	NULL
indicated	NULL
in	NULL
kilodaltons	NULL
.	NULL

(	NULL
D	NULL
)	NULL
Induction	NULL
of	NULL
nuclear	NULL
NF-	NULL
«	NULL
B/Re	NULL
!	NULL

activity	NULL
.	NULL

Jurkat	NULL
T	NULL
cells	NULL
were	NULL
transfected	NULL
by	NULL
electroporation	NULL
with	NULL
expression	NULL
vectors	NULL
encoding	NULL
RelA	NULL
(	NULL
10	NULL
ug	NULL
)	NULL
,	NULL
Tax	NULL
(	NULL
10	NULL
ug	NULL
)	NULL
,	NULL
and	NULL
the	NULL
indicated	NULL
IxBB	NULL
construct	NULL
(	NULL
5	NULL
pg	NULL
)	NULL
.	NULL

After	NULL
48	NULL
h	NULL
of	NULL
growth	NULL
,	NULL
cells	NULL
were	NULL
arrested	NULL
with	NULL
CHX	NULL
for	NULL
2	NULL
h.	NULL
Nuclear	NULL
extracts	NULL
were	NULL
prepared	NULL
and	NULL
analyzed	NULL
in	NULL
gel	NULL
retardation	NULL
assays	NULL
.	NULL

Arrows	NULL
indicate	NULL
the	NULL
positions	NULL
of	NULL
nucleoprotein	NULL
complexes	NULL
containing	NULL
RelA	NULL
homodimers	NULL
(	NULL
upper	NULL
arrow	NULL
)	NULL
and	NULL
RelA/p50	NULL
heterodimers	NULL
(	NULL
lower	NULL
arrow	NULL
)	NULL
.	NULL

taining	NULL
point	NULL
mutations	NULL
at	NULL
all	NULL
other	NULL
potential	NULL
phosphorylation	NULL
sites	NULL
in	NULL
the	NULL
N-terminal	NULL
region	NULL
of	NULL
IxBB	NULL
,	NULL
including	NULL
alanine	NULL
substitutions	NULL
at	NULL
Thr-10	NULL
,	NULL
Ser-45	NULL
,	NULL
and	NULL
Thr-55	NULL
(	NULL
mutants	NULL
T1OA	NULL
,	NULL
$	NULL
45	NULL
,	NULL
and	NULL
T55A	NULL
)	NULL
,	NULL
or	NULL
phenylalanine	NULL
for	NULL
Tyr-53	NULL
(	NULL
mutant	NULL
Y53F	NULL
)	NULL
,	NULL
failed	NULL
to	NULL
inhibit	NULL
the	NULL
Tax	NULL
response	NULL
.	NULL

To	NULL
extend	NULL
these	NULL
findings	NULL
,	NULL
biochemical	NULL
experiments	NULL
were	NULL
performed	NULL
to	NULL
monitor	NULL
the	NULL
stability	NULL
of	NULL
the	NULL
$	NULL
19/23A	NULL
mutant	NULL
of	NULL
IxBB	NULL
when	NULL
coexpressed	NULL
with	NULL
Tax	NULL
in	NULL
vivo	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

3B	NULL
,	NULL
wild-type	NULL
IxBB	NULL
(	NULL
lane	NULL
2	NULL
)	NULL
and	NULL
$	NULL
19/23A	NULL
(	NULL
lane	NULL
3	NULL
)	NULL
were	NULL
expressed	NULL
at	NULL
comparable	NULL
levels	NULL
in	NULL
the	NULL
cytoplasm	NULL
of	NULL
Tax-deficient	NULL
cells	NULL
.	NULL

Furthermore	NULL
,	NULL
the	NULL
$	NULL
19/23A	NULL
mutant	NULL
retained	NULL
the	NULL
capacity	NULL
to	NULL
form	NULL
stable	NULL
cytoplasmic	NULL
complexes	NULL
with	NULL
endogenous	NULL
RelA	NULL
(	NULL
lane	NULL
6	NULL
)	NULL
.	NULL

Consistent	NULL
with	NULL
results	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

2	NULL
,	NULL
steady-state	NULL
levels	NULL
of	NULL
wild-type	NULL
IxBB	NULL
were	NULL
markedly	NULL
reduced	NULL
in	NULL
Jurkat	NULL
T	NULL
cells	NULL
expressing	NULL
Tax	NULL
(	NULL
Fig	NULL
.	NULL

3C	NULL
,	NULL
lane	NULL
2	NULL
)	NULL
.	NULL

However	NULL
,	NULL
the	NULL
$	NULL
19/23A	NULL
mutant	NULL
escaped	NULL
from	NULL
Tax-induced	NULL
breakdown	NULL
(	NULL
lane	NULL
4	NULL
)	NULL
.	NULL

Taken	NULL
together	NULL
,	NULL
these	NULL
in	NULL
vivo	NULL
results	NULL
confirmed	NULL
that	NULL
serines	NULL
19	NULL
and	NULL
23	NULL
of	NULL
IxBB	NULL
are	NULL
required	NULL
for	NULL
proteolytic	NULL
inactivation	NULL
by	NULL
Tax	NULL
.	NULL

Mor	NULL
.	NULL

CELL	NULL
.	NULL

BioL	NULL
.	NULL

We	NULL
next	NULL
performed	NULL
gel	NULL
retardation	NULL
studies	NULL
to	NULL
determine	NULL
whether	NULL
the	NULL
relative	NULL
stabilities	NULL
of	NULL
these	NULL
inhibitors	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
Tax	NULL
correlated	NULL
with	NULL
the	NULL
induction	NULL
of	NULL
nuclear	NULL
NF-	NULL
«	NULL
B	NULL
expression	NULL
.	NULL

Jurkat	NULL
T	NULL
cells	NULL
were	NULL
transfected	NULL
with	NULL
expression	NULL
vectors	NULL
encoding	NULL
RelA	NULL
,	NULL
Tax	NULL
,	NULL
and	NULL
either	NULL
wild-type	NULL
IBB	NULL
or	NULL
mutant	NULL
$	NULL
19/23A	NULL
.	NULL

Nuclear	NULL
extracts	NULL
were	NULL
prepared	NULL
from	NULL
recipient	NULL
cells	NULL
and	NULL
analyzed	NULL
for	NULL
«	NULL
B-specific	NULL
DNA	NULL
binding	NULL
activity	NULL
in	NULL
mobility	NULL
shift	NULL
assays	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

3D	NULL
(	NULL
lanes	NULL
1	NULL
and	NULL
2	NULL
)	NULL
,	NULL
significant	NULL
amounts	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
were	NULL
detected	NULL
in	NULL
nuclear	NULL
extracts	NULL
from	NULL
control	NULL
cells	NULL
overexpressing	NULL
RelA	NULL
but	NULL
lacking	NULL
ectopic	NULL
IxBB	NULL
.	NULL

However	NULL
,	NULL
coexpression	NULL
with	NULL
either	NULL
wild-type	NULL
IBB	NULL
(	NULL
lane	NULL
3	NULL
)	NULL
or	NULL
$	NULL
19/23A	NULL
(	NULL
lane	NULL
5	NULL
)	NULL
blocked	NULL
the	NULL
formation	NULL
of	NULL
these	NULL
nucleoprotein	NULL
complexes	NULL
.	NULL

In	NULL
cells	NULL
expressing	NULL
HTLV-1	NULL
Tax	NULL
,	NULL
the	NULL
wild-type	NULL
inhibitor	NULL
was	NULL
efficiently	NULL
inactivated	NULL
,	NULL
as	NULL
evidenced	NULL
by	NULL
the	NULL
accumulation	NULL
of	NULL
nuclear	NULL
NF-	NULL
«	NULL
B	NULL
(	NULL
lane	NULL
4	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
Tax	NULL
failed	NULL
to	NULL
mobilize	NULL
NF-kB	NULL
complexes	NULL
containing	NULL
the	NULL
$	NULL
19/23A	NULL
mutant	NULL
(	NULL
lane	NULL
6	NULL
)	NULL
.	NULL

We	NULL
conclude	NULL
that	NULL
Tax	NULL
targets	NULL
both	NULL
IkxBa	NULL
and	NULL
IxBB	NULL
for	NULL
degradation	NULL
through	NULL
a	NULL
related	NULL
proteasome-dependent	NULL
mechanism	NULL
,	NULL
which	NULL
requires	NULL
the	NULL
presence	NULL
of	NULL
conserved	NULL
serine	NULL
residues	NULL
in	NULL
their	NULL
N-terminal	NULL
regions	NULL
(	NULL
13	NULL
,	NULL
14	NULL
,	NULL
78	NULL
)	NULL
.	NULL

Differential	NULL
expression	NULL
of	NULL
IB	NULL
proteins	NULL
in	NULL
HTLV-1-infected	NULL
T	NULL
lymphocytes	NULL
.	NULL

To	NULL
assess	NULL
the	NULL
physiologic	NULL
relevance	NULL
of	NULL
our	NULL
observations	NULL
with	NULL
transfected	NULL
cells	NULL
,	NULL
we	NULL
next	NULL
examined	NULL
the	NULL
functional	NULL
interplay	NULL
between	NULL
IxBB	NULL
and	NULL
Tax	NULL
in	NULL
HTLV-1-infected	NULL
T	NULL
lymphocytes	NULL
.	NULL

For	NULL
these	NULL
studies	NULL
,	NULL
we	NULL
used	NULL
,	NULL
in	NULL
addition	NULL
to	NULL
Jurkat	NULL
T	NULL
cells	NULL
,	NULL
five	NULL
independent	NULL
HTLV-1-transformed	NULL
cell	NULL
lines	NULL
,	NULL
SLB-1	NULL
(	NULL
41	NULL
)	NULL
,	NULL
Hut102	NULL
(	NULL
25	NULL
)	NULL
,	NULL
C8166	NULL
(	NULL
60	NULL
)	NULL
,	NULL
MT-2	NULL
(	NULL
48	NULL
)	NULL
,	NULL
and	NULL
MT-4	NULL
(	NULL
47	NULL
)	NULL
.	NULL

The	NULL
SLB-1	NULL
,	NULL
Hut102	NULL
,	NULL
and	NULL
MT-2	NULL
cell	NULL
lines	NULL
are	NULL
chronically	NULL
infected	NULL
with	NULL
HTLV-1	NULL
and	NULL
produce	NULL
infectious	NULL
virions	NULL
capable	NULL
of	NULL
transforming	NULL
primary	NULL
human	NULL
T	NULL
lymphocytes	NULL
.	NULL

The	NULL
C8166	NULL
and	NULL
MT-4	NULL
cells	NULL
served	NULL
as	NULL
controls	NULL
for	NULL
Tax-specific	NULL
effects	NULL
.	NULL

Whereas	NULL
C8166	NULL
cells	NULL
are	NULL
infected	NULL
with	NULL
a	NULL
defective	NULL
HTLV-1	NULL
that	NULL
selectively	NULL
expresses	NULL
Tax	NULL
,	NULL
MT-4	NULL
cells	NULL
harbor	NULL
a	NULL
partially	NULL
deleted	NULL
HTLV-1	NULL
genome	NULL
that	NULL
fails	NULL
to	NULL
direct	NULL
the	NULL
synthesis	NULL
of	NULL
a	NULL
functional	NULL
Tax	NULL
protein	NULL
.	NULL

In	NULL
agreement	NULL
with	NULL
prior	NULL
studies	NULL
(	NULL
42	NULL
,	NULL
72	NULL
)	NULL
,	NULL
immunoblotting	NULL
with	NULL
peptide-specific	NULL
antisera	NULL
revealed	NULL
the	NULL
presence	NULL
of	NULL
two	NULL
prominent	NULL
isoforms	NULL
of	NULL
IxBa	NULL
in	NULL
cytoplasmic	NULL
extracts	NULL
from	NULL
SLB-1	NULL
,	NULL
Hut102	NULL
,	NULL
C8166	NULL
,	NULL
and	NULL
MT-2	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

4A	NULL
,	NULL
lanes	NULL
2	NULL
to	NULL
5	NULL
)	NULL
but	NULL
not	NULL
in	NULL
MT-4	NULL
(	NULL
lane	NULL
6	NULL
)	NULL
or	NULL
uninfected	NULL
Jurkat	NULL
T	NULL
(	NULL
lane	NULL
1	NULL
)	NULL
cells	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

4D	NULL
,	NULL
the	NULL
more	NULL
slowly	NULL
migrating	NULL
species	NULL
was	NULL
sensitive	NULL
to	NULL
treatment	NULL
with	NULL
calf	NULL
intestinal	NULL
phosphatase	NULL
(	NULL
lane	NULL
2	NULL
)	NULL
and	NULL
thus	NULL
likely	NULL
represents	NULL
the	NULL
hyperphosphorylated	NULL
form	NULL
of	NULL
IxBa	NULL
that	NULL
is	NULL
modified	NULL
at	NULL
Ser-32	NULL
and	NULL
Ser-36	NULL
(	NULL
13	NULL
,	NULL
14	NULL
,	NULL
42	NULL
,	NULL
72	NULL
,	NULL
78	NULL
)	NULL
.	NULL

Consistent	NULL
with	NULL
previously	NULL
published	NULL
reports	NULL
(	NULL
13	NULL
,	NULL
37	NULL
,	NULL
42	NULL
,	NULL
72	NULL
)	NULL
,	NULL
the	NULL
presence	NULL
of	NULL
the	NULL
hyperphosphorylated	NULL
isoform	NULL
of	NULL
IxBa	NULL
was	NULL
dependent	NULL
on	NULL
Tax	NULL
expression	NULL
(	NULL
Fig	NULL
.	NULL

4C	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
to	NULL
IxBa	NULL
,	NULL
the	NULL
steady-state	NULL
level	NULL
of	NULL
IxBB	NULL
protein	NULL
was	NULL
drastically	NULL
reduced	NULL
in	NULL
each	NULL
of	NULL
the	NULL
cell	NULL
lines	NULL
expressing	NULL
Tax	NULL
(	NULL
Fig	NULL
.	NULL

4B	NULL
,	NULL
lanes	NULL
2	NULL
to	NULL
5	NULL
)	NULL
.	NULL

However	NULL
,	NULL
IxBB	NULL
was	NULL
readily	NULL
detected	NULL
in	NULL
Tax-deficient	NULL
cells	NULL
(	NULL
lanes	NULL
1	NULL
and	NULL
6	NULL
)	NULL
.	NULL

These	NULL
results	NULL
suggest	NULL
that	NULL
IxBB	NULL
protein	NULL
expression	NULL
is	NULL
downregulated	NULL
in	NULL
HTLV-1-infected	NULL
cells	NULL
by	NULL
a	NULL
Tax-dependent	NULL
mechanism	NULL
.	NULL

The	NULL
peptide	NULL
aldehyde	NULL
MG132	NULL
blocks	NULL
NF-kB	NULL
induction	NULL
by	NULL
preventing	NULL
proteasome-mediated	NULL
degradation	NULL
of	NULL
hyperphosphorylated	NULL
IxBa	NULL
(	NULL
16	NULL
,	NULL
53	NULL
)	NULL
.	NULL

To	NULL
determine	NULL
its	NULL
effects	NULL
on	NULL
Tax-mediated	NULL
turnover	NULL
of	NULL
endogenous	NULL
IxBa	NULL
and	NULL
IxBB	NULL
,	NULL
we	NULL
treated	NULL
HTLV-1-transformed	NULL
cell	NULL
lines	NULL
with	NULL
MG132	NULL
and	NULL
monitored	NULL
IxB	NULL
expression	NULL
by	NULL
immunoblot	NULL
analysis	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

5A	NULL
,	NULL
incubation	NULL
of	NULL
C8166	NULL
cells	NULL
with	NULL
MG132	NULL
led	NULL
to	NULL
the	NULL
rapid	NULL
accumulation	NULL
of	NULL
the	NULL
hyperphosphorylated	NULL
form	NULL
of	NULL
IkBa	NULL
(	NULL
top	NULL
panel	NULL
)	NULL
.	NULL

The	NULL
observed	NULL
increase	NULL
in	NULL
cytoplasmic	NULL
IkBa	NULL
protein	NULL
was	NULL
due	NULL
to	NULL
repression	NULL
of	NULL
Tax-mediated	NULL
proteolysis	NULL
rather	NULL
than	NULL
basal	NULL
turnover	NULL
,	NULL
because	NULL
Tax-deficient	NULL
MT	NULL
-4	NULL
cells	NULL
maintained	NULL
a	NULL
constant	NULL
steady-state	NULL
level	NULL
of	NULL
IxBa	NULL
over	NULL
the	NULL
same	NULL
time	NULL
course	NULL
(	NULL
Fig	NULL
.	NULL

5A	NULL
,	NULL
bottom	NULL
panel	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
at	NULL
doses	NULL
sufficient	NULL
to	NULL
prevent	NULL
proteolytic	NULL
breakdown	NULL
of	NULL
ectopic	NULL
IkBB	NULL
(	NULL
Fig	NULL
.	NULL

2C	NULL
)	NULL
,	NULL
Vou	NULL
.	NULL

16	NULL
,	NULL
1996	NULL
A	NULL
_/	NULL
IkBa-®	NULL
)	NULL
me*	NULL
se	NULL
M	NULL
~NirBa	NULL
1	NULL
1	NULL
I	NULL
I	NULL
I	NULL
I	NULL
B	NULL
\	NULL
v	NULL
~	NULL
‘	NULL
**	NULL
«	NULL
--	NULL
IBB	NULL
I	NULL
1	NULL
I	NULL
1	NULL
1	NULL
I	NULL
C	NULL
UND	NULL
aar	NULL
cam	NULL
--	NULL
-	NULL
Tax	NULL
So	NULL
Na	NULL
Sy	NULL
Sa	NULL
Sy	NULL
NR	NULL
G	NULL
Gs	NULL
4	NULL
Oo	NULL
In	NULL
4	NULL
(	NULL
42.6	NULL
?	NULL

(	NULL
Q	NULL
,	NULL
000	NULL
(	NULL
9,6	NULL
)	NULL
‘	NULL
e	NULL
7:7	NULL
o	NULL
D	NULL
1	NULL
3	NULL
1	NULL
1	NULL
_/	NULL
~*	NULL
ikBa	NULL
CIP	NULL
:	NULL
_-	NULL
+	NULL
+	NULL
INH	NULL
:	NULL
_-	NULL
-	NULL
+	NULL
FIG	NULL
.	NULL

4	NULL
.	NULL

IxBB	NULL
protein	NULL
expression	NULL
is	NULL
downregulated	NULL
in	NULL
HTLV-1-infected	NULL
T	NULL
lymphocytes	NULL
.	NULL

Equivalent	NULL
amounts	NULL
of	NULL
cytoplasmic	NULL
protein	NULL
(	NULL
100	NULL
mg	NULL
)	NULL
from	NULL
either	NULL
uninfected	NULL
Jurkat	NULL
T	NULL
cells	NULL
(	NULL
lane	NULL
1	NULL
)	NULL
or	NULL
the	NULL
indicated	NULL
HTLV-1-infected	NULL
T-cell	NULL
lines	NULL
(	NULL
lanes	NULL
2	NULL
to	NULL
6	NULL
)	NULL
were	NULL
resolved	NULL
by	NULL
SDS-PAGE	NULL
and	NULL
analyzed	NULL
by	NULL
immunoblotting	NULL
with	NULL
a	NULL
peptide-specific	NULL
antibody	NULL
raised	NULL
against	NULL
either	NULL
IxBa	NULL
(	NULL
amino	NULL
acids	NULL
289	NULL
to	NULL
317	NULL
;	NULL
A	NULL
)	NULL
,	NULL
IxBB	NULL
(	NULL
amino	NULL
acids	NULL
330-359	NULL
;	NULL
B	NULL
)	NULL
,	NULL
or	NULL
Tax	NULL
(	NULL
C	NULL
)	NULL
.	NULL

Similar	NULL
results	NULL
were	NULL
obtained	NULL
when	NULL
an	NULL
independent	NULL
IxBB-specific	NULL
antiserum	NULL
generated	NULL
against	NULL
the	NULL
full-length	NULL
inhibitor	NULL
was	NULL
used	NULL
.	NULL

(	NULL
D	NULL
)	NULL
Cytoplasmic	NULL
extracts	NULL
from	NULL
MT-2	NULL
cells	NULL
were	NULL
incubated	NULL
in	NULL
the	NULL
presence	NULL
(	NULL
lanes	NULL
2	NULL
and	NULL
3	NULL
)	NULL
or	NULL
absence	NULL
(	NULL
lane	NULL
1	NULL
)	NULL
of	NULL
calf	NULL
intestinal	NULL
phosphatase	NULL
(	NULL
CIP	NULL
)	NULL
and	NULL
then	NULL
subjected	NULL
to	NULL
immunoblot	NULL
analysis	NULL
with	NULL
an	NULL
IxBo-specific	NULL
antiserum	NULL
.	NULL

Control	NULL
reactions	NULL
(	NULL
lane	NULL
3	NULL
)	NULL
were	NULL
supplemented	NULL
with	NULL
a	NULL
previously	NULL
described	NULL
cocktail	NULL
of	NULL
phosphatase	NULL
inhibitors	NULL
(	NULL
INH	NULL
)	NULL
(	NULL
13	NULL
)	NULL
.	NULL

MG132	NULL
failed	NULL
to	NULL
affect	NULL
the	NULL
cytoplasmic	NULL
pool	NULL
of	NULL
endogenous	NULL
IxBB	NULL
(	NULL
Fig	NULL
.	NULL

5B	NULL
)	NULL
.	NULL

These	NULL
results	NULL
with	NULL
endogenous	NULL
IxBB	NULL
were	NULL
recapitulated	NULL
in	NULL
assays	NULL
using	NULL
three	NULL
independent	NULL
Tax-expressing	NULL
cell	NULL
lines	NULL
,	NULL
SLB-1	NULL
,	NULL
Hut102	NULL
,	NULL
and	NULL
MT-2	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

The	NULL
capacity	NULL
of	NULL
MG132	NULL
to	NULL
mediate	NULL
the	NULL
rapid	NULL
accumulation	NULL
of	NULL
endogenous	NULL
IxBa	NULL
but	NULL
not	NULL
IxBB	NULL
suggests	NULL
that	NULL
these	NULL
two	NULL
inhibitors	NULL
are	NULL
synthesized	NULL
at	NULL
different	NULL
rates	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
Tax	NULL
.	NULL

HTLV-1	NULL
Tax	NULL
transcriptionally	NULL
induces	NULL
IxBa	NULL
but	NULL
not	NULL
IBB	NULL
.	NULL

During	NULL
normal	NULL
T-cell	NULL
activation	NULL
,	NULL
a	NULL
transient	NULL
NF-kB	NULL
response	NULL
is	NULL
maintained	NULL
by	NULL
an	NULL
autoregulatory	NULL
mechanism	NULL
that	NULL
involves	NULL
NF-xB-directed	NULL
transcription	NULL
of	NULL
the	NULL
IxBa	NULL
gene	NULL
(	NULL
8	NULL
,	NULL
15	NULL
,	NULL
17	NULL
,	NULL
20	NULL
,	NULL
30	NULL
,	NULL
36	NULL
,	NULL
43	NULL
,	NULL
73	NULL
)	NULL
.	NULL

Although	NULL
the	NULL
cis-acting	NULL
elements	NULL
that	NULL
regulate	NULL
the	NULL
IxBB	NULL
gene	NULL
remain	NULL
undefined	NULL
,	NULL
a	NULL
recent	NULL
report	NULL
suggests	NULL
that	NULL
this	NULL
transcription	NULL
unit	NULL
is	NULL
not	NULL
under	NULL
NF-kB	NULL
control	NULL
(	NULL
77	NULL
)	NULL
.	NULL

On	NULL
the	NULL
basis	NULL
of	NULL
these	NULL
prior	NULL
observations	NULL
,	NULL
we	NULL
reasoned	NULL
that	NULL
the	NULL
distinct	NULL
patterns	NULL
of	NULL
IxB	NULL
expression	NULL
observed	NULL
in	NULL
HTLV-1-infected	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
and	NULL
5	NULL
)	NULL
may	NULL
reflect	NULL
the	NULL
capacity	NULL
of	NULL
Tax	NULL
to	NULL
selectively	NULL
stimulate	NULL
NF-	NULL
«	NULL
xB-dependent	NULL
transcription	NULL
of	NULL
the	NULL
IxBa	NULL
gene	NULL
.	NULL

To	NULL
test	NULL
this	NULL
hypothesis	NULL
,	NULL
we	NULL
examined	NULL
the	NULL
steady-state	NULL
levels	NULL
of	NULL
IxBa	NULL
and	NULL
IxBB	NULL
transcripts	NULL
in	NULL
HTLV-1-transformed	NULL
cell	NULL
lines	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

6A	NULL
,	NULL
IxBa	NULL
mRNA	NULL
pools	NULL
were	NULL
dramatically	NULL
elevated	NULL
in	NULL
virally	NULL
infected	NULL
cells	NULL
expressing	NULL
Tax	NULL
(	NULL
lanes	NULL
2	NULL
to	NULL
4	NULL
)	NULL
relative	NULL
to	NULL
the	NULL
level	NULL
observed	NULL
in	NULL
Tax-deficient	NULL
MT	NULL
-4	NULL
cells	NULL
(	NULL
lane	NULL
1	NULL
)	NULL
.	NULL

In	NULL
sharp	NULL
contrast	NULL
to	NULL
IxBa	NULL
,	NULL
comparable	NULL
amounts	NULL
of	NULL
IkBB	NULL
mRNA	NULL
were	NULL
detected	NULL
in	NULL
each	NULL
of	NULL
these	NULL
transformed	NULL
cell	NULL
lines	NULL
(	NULL
Fig	NULL
.	NULL

6A	NULL
,	NULL
middle	NULL
panel	NULL
)	NULL
.	NULL

Experiments	NULL
were	NULL
next	NULL
performed	NULL
to	NULL
determine	NULL
whether	NULL
the	NULL
NF-	NULL
«	NULL
B-activating	NULL
function	NULL
of	NULL
Tax	NULL
is	NULL
required	NULL
to	NULL
elicit	NULL
these	NULL
transcriptional	NULL
responses	NULL
.	NULL

For	NULL
these	NULL
studies	NULL
,	NULL
we	NULL
examined	NULL
the	NULL
steady-state	NULL
levels	NULL
of	NULL
IxB	NULL
transcripts	NULL
in	NULL
Jurkat	NULL
T	NULL
cells	NULL
following	NULL
transfection	NULL
with	NULL
plasmids	NULL
encoding	NULL
wild-type	NULL
Tax	NULL
(	NULL
Tax-WT	NULL
)	NULL
or	NULL
mutants	NULL
of	NULL
Tax	NULL
that	NULL
are	NULL
unable	NULL
to	NULL
stimulate	NULL
either	NULL
the	NULL
CREB/ATF	NULL
(	NULL
Tax-M47	NULL
)	NULL
or	NULL
the	NULL
NF-	NULL
«	NULL
B/Rel	NULL
(	NULL
Tax-M22	NULL
)	NULL
transcription	NULL
factor	NULL
pathway	NULL
(	NULL
68	NULL
)	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

6B	NULL
,	NULL
IxBa	NULL
but	NULL
not	NULL
IxBB	NULL
mRNA	NULL
expression	NULL
was	NULL
markedly	NULL
upregulated	NULL
in	NULL
cells	NULL
expressing	NULL
either	NULL
Tax-WT	NULL
(	NULL
lane	NULL
2	NULL
)	NULL
or	NULL
Tax-M47	NULL
(	NULL
lane	NULL
4	NULL
)	NULL
relative	NULL
DEREGULATION	NULL
OF	NULL
IkBB	NULL
BY	NULL
HTLV-1	NULL
Tax	NULL
2087	NULL
A	NULL
10	NULL
203	NULL
I	NULL
I	NULL
I	NULL
4	NULL
5	NULL
e	NULL
_	NULL
,	NULL
IkBa®	NULL
CBE	NULL
u-	NULL
``	NULL
``	NULL
o	NULL
wr	NULL
<	NULL
lige	NULL
,	NULL
Lo	NULL
b	NULL
oa	NULL
1	NULL
MT-4	NULL
--	NULL
-	NULL
-	NULL
-IxBa	NULL
a	NULL
No	NULL
N	NULL
NN	NULL
&	NULL
0	NULL
1	NULL
2	NULL
41	NULL
%	NULL
MG132	NULL
(	NULL
Hours	NULL
)	NULL
B	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
I	NULL
I	NULL
I	NULL
I	NULL
I	NULL
C8166	NULL
_-	NULL
.	NULL

-IkBB	NULL
I	NULL
I	NULL
I	NULL
I	NULL
I	NULL
MT-4	NULL
<	NULL
--	NULL
-	NULL
f	NULL
-IkBB	NULL
\	NULL
\	NULL
\	NULL
\	NULL
\	NULL
10	NULL
2	NULL
4	NULL
y	NULL
*~	NULL
MG132	NULL
Hours	NULL
)	NULL
FIG	NULL
.	NULL

5	NULL
.	NULL

Inhibition	NULL
of	NULL
proteasome	NULL
activity	NULL
in	NULL
HTLV-1-infected	NULL
lymphocytes	NULL
leads	NULL
to	NULL
the	NULL
accumulation	NULL
of	NULL
IxBa	NULL
but	NULL
not	NULL
IBB	NULL
.	NULL

(	NULL
A	NULL
)	NULL
The	NULL
HTLV-l-infected	NULL
T-cell	NULL
lines	NULL
C8166	NULL
(	NULL
upper	NULL
panel	NULL
)	NULL
and	NULL
MT-4	NULL
(	NULL
lower	NULL
panel	NULL
)	NULL
were	NULL
treated	NULL
with	NULL
the	NULL
proteasome	NULL
inhibitor	NULL
MG132	NULL
(	NULL
100	NULL
M	NULL
)	NULL
for	NULL
the	NULL
indicated	NULL
periods	NULL
of	NULL
time	NULL
.	NULL

Cytoplasmic	NULL
extracts	NULL
were	NULL
prepared	NULL
and	NULL
analyzed	NULL
by	NULL
immunoblotting	NULL
with	NULL
peptide-specific	NULL
IxBa	NULL
antisera	NULL
(	NULL
lanes	NULL
2	NULL
to	NULL
5	NULL
)	NULL
.	NULL

Equivalent	NULL
amounts	NULL
of	NULL
cytoplasmic	NULL
protein	NULL
from	NULL
Jurkat	NULL
T	NULL
cells	NULL
were	NULL
analyzed	NULL
in	NULL
parallel	NULL
(	NULL
lane	NULL
1	NULL
)	NULL
as	NULL
a	NULL
control	NULL
for	NULL
basal	NULL
levels	NULL
of	NULL
IxBa	NULL
expression	NULL
in	NULL
uninfected	NULL
T	NULL
lymphocytes	NULL
.	NULL

Major	NULL
immunoreactive	NULL
IxB	NULL
species	NULL
are	NULL
indicated	NULL
.	NULL

The	NULL
contrasting	NULL
steady-state	NULL
expression	NULL
of	NULL
IxBa	NULL
«	NULL
in	NULL
untreated	NULL
C8166	NULL
cells	NULL
(	NULL
lane	NULL
2	NULL
)	NULL
relative	NULL
to	NULL
that	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

4	NULL
(	NULL
lane	NULL
4	NULL
)	NULL
reflects	NULL
differences	NULL
in	NULL
total	NULL
protein	NULL
input	NULL
and	NULL
film	NULL
exposure	NULL
times	NULL
.	NULL

(	NULL
B	NULL
)	NULL
C8166	NULL
(	NULL
upper	NULL
pane	NULL
!	NULL
)	NULL

and	NULL
MT-4	NULL
(	NULL
lower	NULL
panel	NULL
)	NULL
cells	NULL
were	NULL
treated	NULL
with	NULL
MG132	NULL
for	NULL
the	NULL
indicated	NULL
periods	NULL
of	NULL
time	NULL
.	NULL

Cytoplasmic	NULL
proteins	NULL
were	NULL
processed	NULL
as	NULL
described	NULL
above	NULL
and	NULL
immunoblotted	NULL
with	NULL
IxBB-specific	NULL
antiserum	NULL
generated	NULL
against	NULL
the	NULL
full-length	NULL
inhibitor	NULL
(	NULL
lanes	NULL
2	NULL
to	NULL
5	NULL
)	NULL
.	NULL

Control	NULL
experiments	NULL
performed	NULL
with	NULL
equivalent	NULL
amounts	NULL
of	NULL
Jurkat	NULL
T	NULL
cell	NULL
extracts	NULL
are	NULL
shown	NULL
in	NULL
lane	NULL
1.	NULL
to	NULL
control	NULL
transfectants	NULL
(	NULL
lane	NULL
1	NULL
)	NULL
.	NULL

These	NULL
stimulatory	NULL
effects	NULL
were	NULL
dependent	NULL
on	NULL
the	NULL
NF-	NULL
«	NULL
B-inducing	NULL
function	NULL
of	NULL
Tax	NULL
,	NULL
since	NULL
Tax-M22	NULL
failed	NULL
to	NULL
enhance	NULL
IxBa	NULL
mRNA	NULL
expression	NULL
(	NULL
lane	NULL
3	NULL
)	NULL
.	NULL

Consistent	NULL
with	NULL
these	NULL
findings	NULL
,	NULL
the	NULL
level	NULL
of	NULL
IxBa	NULL
transcripts	NULL
was	NULL
significantly	NULL
increased	NULL
in	NULL
cells	NULL
expressing	NULL
the	NULL
RelA	NULL
transactivating	NULL
subunit	NULL
of	NULL
NF-kB	NULL
(	NULL
Fig	NULL
.	NULL

6C	NULL
,	NULL
lane	NULL
2	NULL
)	NULL
but	NULL
not	NULL
the	NULL
p50	NULL
A	NULL
B	NULL
C	NULL
1	NULL
20s	NULL
4	NULL
10	NULL
2	NULL
s	NULL
4	NULL
1	NULL
203	NULL
bob	NULL
dou	NULL
Pog	NULL
au	NULL
bob	NULL
a	NULL
®	NULL
``	NULL
``	NULL
.	NULL

#	NULL
Lod	NULL
|	NULL
I	NULL
j|	NULL
1d	NULL
100	NULL
Lob	NULL
g	NULL
d	NULL
Pog	NULL
Gd	NULL
a	NULL
Lob	NULL
a	NULL
caro	NULL
,	NULL
-	NULL
mesa	NULL
===	NULL
b	NULL
G	NULL
AL	NULL
bol	NULL
AL	NULL
b	NULL
lL	NULL
An	NULL
.	NULL

47	NULL
.	NULL

%	NULL
.O	NULL
bnt	NULL
A	NULL
A	NULL
on	NULL
0	NULL
2	NULL
y	NULL
/§	NULL
<	NULL
°	NULL
(	NULL
Qz0	NULL
’	NULL
6	NULL
‘	NULL
6\	NULL
092	NULL
;	NULL
624123477	NULL
)	NULL
041	NULL
P51	NULL
?	NULL

%	NULL
FIG	NULL
.	NULL

6	NULL
.	NULL

Northern	NULL
blot	NULL
analysis	NULL
of	NULL
IxB	NULL
mRNA	NULL
transcripts	NULL
.	NULL

Poly	NULL
(	NULL
A	NULL
)	NULL
*	NULL
RNA	NULL
was	NULL
prepared	NULL
from	NULL
HTLV-1-infected	NULL
T	NULL
cell	NULL
lines	NULL
(	NULL
A	NULL
)	NULL
,	NULL
human	NULL
Jurkat	NULL
T	NULL
cells	NULL
transfected	NULL
with	NULL
the	NULL
indicated	NULL
Tax	NULL
effector	NULL
plasmids	NULL
(	NULL
B	NULL
)	NULL
,	NULL
or	NULL
transfectants	NULL
overexpressing	NULL
the	NULL
indicated	NULL
NF-xB	NULL
subunits	NULL
(	NULL
C	NULL
)	NULL
.	NULL

In	NULL
all	NULL
cases	NULL
,	NULL
poly	NULL
(	NULL
A	NULL
)	NULL
*	NULL
RNA	NULL
was	NULL
selected	NULL
from	NULL
~750	NULL
ug	NULL
of	NULL
total	NULL
RNA	NULL
.	NULL

Following	NULL
fractionation	NULL
on	NULL
formaldehyde-agarose	NULL
gels	NULL
,	NULL
RNA	NULL
was	NULL
transferred	NULL
to	NULL
Zeta	NULL
Probe	NULL
membranes	NULL
and	NULL
sequentially	NULL
hybridized	NULL
with	NULL
a	NULL
°°P-labeled	NULL
cDNA	NULL
probe	NULL
(	NULL
~10°	NULL
cpm/ml	NULL
!	NULL
)	NULL

for	NULL
IxBa	NULL
,	NULL
IBB	NULL
,	NULL
and	NULL
glyceralde-hyde	NULL
3-phosphate	NULL
dehydrogenase	NULL
(	NULL
GAPDH	NULL
)	NULL
.	NULL

2088	NULL
McKINSEY	NULL
ET	NULL
AL	NULL
.	NULL

subunit	NULL
(	NULL
lane	NULL
3	NULL
)	NULL
,	NULL
which	NULL
lacks	NULL
a	NULL
transcriptional	NULL
activation	NULL
domain	NULL
(	NULL
6	NULL
,	NULL
58	NULL
,	NULL
63	NULL
)	NULL
.	NULL

These	NULL
results	NULL
confirmed	NULL
that	NULL
the	NULL
NF-	NULL
«	NULL
kB-inducing	NULL
activity	NULL
of	NULL
Tax	NULL
accounts	NULL
for	NULL
the	NULL
high-level	NULL
expression	NULL
of	NULL
IxBa	NULL
mRNA	NULL
in	NULL
HTLV-1-infected	NULL
lymphocytes	NULL
.	NULL

Furthermore	NULL
,	NULL
these	NULL
findings	NULL
establish	NULL
a	NULL
strong	NULL
correlation	NULL
between	NULL
the	NULL
chronic	NULL
downregulation	NULL
of	NULL
IxBB	NULL
protein	NULL
expression	NULL
and	NULL
the	NULL
failure	NULL
of	NULL
Tax	NULL
to	NULL
induce	NULL
IkxBB	NULL
gene	NULL
transcription	NULL
in	NULL
virus-infected	NULL
cells	NULL
.	NULL

DISCUSSION	NULL
The	NULL
Tax	NULL
protein	NULL
of	NULL
HTLV-1	NULL
is	NULL
a	NULL
potent	NULL
transcriptional	NULL
activator	NULL
with	NULL
demonstrated	NULL
oncogenic	NULL
potential	NULL
(	NULL
31	NULL
,	NULL
50	NULL
,	NULL
55	NULL
,	NULL
69	NULL
,	NULL
70	NULL
,	NULL
75	NULL
)	NULL
.	NULL

This	NULL
transforming	NULL
protein	NULL
has	NULL
the	NULL
capacity	NULL
to	NULL
activate	NULL
the	NULL
functional	NULL
expression	NULL
of	NULL
various	NULL
members	NULL
of	NULL
the	NULL
NF-	NULL
«	NULL
B/	NULL
Rel	NULL
family	NULL
of	NULL
transcription	NULL
factors	NULL
(	NULL
5	NULL
,	NULL
44	NULL
,	NULL
59	NULL
)	NULL
.	NULL

Recent	NULL
studies	NULL
with	NULL
mice	NULL
transgenic	NULL
for	NULL
the	NULL
tax	NULL
gene	NULL
suggest	NULL
that	NULL
the	NULL
constitutive	NULL
pattern	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
induced	NULL
in	NULL
HTLV-1-infected	NULL
cells	NULL
is	NULL
required	NULL
to	NULL
maintain	NULL
the	NULL
transformed	NULL
phenotype	NULL
(	NULL
40	NULL
)	NULL
.	NULL

We	NULL
have	NULL
focused	NULL
on	NULL
defining	NULL
how	NULL
Tax	NULL
subverts	NULL
the	NULL
action	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
in	NULL
CD4*	NULL
T	NULL
lymphocytes	NULL
,	NULL
the	NULL
in	NULL
vivo	NULL
target	NULL
for	NULL
HTLV-1-induced	NULL
transformation	NULL
.	NULL

Insights	NULL
into	NULL
the	NULL
precise	NULL
nature	NULL
of	NULL
this	NULL
virus-host	NULL
interaction	NULL
have	NULL
been	NULL
complicated	NULL
by	NULL
the	NULL
capacity	NULL
of	NULL
Tax	NULL
to	NULL
assemble	NULL
with	NULL
multiple	NULL
components	NULL
of	NULL
the	NULL
NF-kB	NULL
pathway	NULL
(	NULL
10	NULL
,	NULL
32	NULL
,	NULL
33	NULL
,	NULL
81	NULL
)	NULL
.	NULL

However	NULL
,	NULL
recent	NULL
experiments	NULL
have	NULL
revealed	NULL
a	NULL
direct	NULL
mechanistic	NULL
link	NULL
between	NULL
the	NULL
abilities	NULL
of	NULL
Tax	NULL
to	NULL
activate	NULL
NF-kB	NULL
and	NULL
to	NULL
stimulate	NULL
degradation	NULL
of	NULL
IxBa	NULL
by	NULL
the	NULL
268	NULL
proteasome	NULL
(	NULL
13	NULL
,	NULL
62	NULL
)	NULL
.	NULL

We	NULL
demonstrate	NULL
here	NULL
that	NULL
Tax	NULL
also	NULL
induces	NULL
proteasome-dependent	NULL
degradation	NULL
of	NULL
IxBB	NULL
,	NULL
a	NULL
recently	NULL
cloned	NULL
member	NULL
of	NULL
the	NULL
IxB	NULL
family	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
inhibitors	NULL
(	NULL
77	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
Tax	NULL
mobilizes	NULL
not	NULL
one	NULL
but	NULL
two	NULL
distinct	NULL
pools	NULL
of	NULL
cytoplasmic	NULL
NF-complexes	NULL
to	NULL
the	NULL
nucleus	NULL
.	NULL

The	NULL
dual	NULL
specificity	NULL
of	NULL
Tax	NULL
for	NULL
IxBa	NULL
and	NULL
IxBB	NULL
likely	NULL
contributes	NULL
to	NULL
the	NULL
mechanism	NULL
by	NULL
which	NULL
HTLV-1	NULL
deregulates	NULL
the	NULL
expression	NULL
of	NULL
growth-related	NULL
genes	NULL
under	NULL
NF-kB	NULL
control	NULL
(	NULL
5	NULL
,	NULL
19	NULL
,	NULL
27	NULL
,	NULL
39	NULL
,	NULL
44	NULL
,	NULL
59	NULL
)	NULL
.	NULL

During	NULL
a	NULL
normal	NULL
immune	NULL
response	NULL
,	NULL
IxBa	NULL
«	NULL
is	NULL
rapidly	NULL
phosphorylated	NULL
and	NULL
then	NULL
completely	NULL
degraded	NULL
via	NULL
the	NULL
ubiquitin-proteasome	NULL
pathway	NULL
(	NULL
13	NULL
,	NULL
14	NULL
,	NULL
16	NULL
,	NULL
62	NULL
,	NULL
78	NULL
,	NULL
79	NULL
)	NULL
.	NULL

Recent	NULL
studies	NULL
have	NULL
suggested	NULL
that	NULL
signal-dependent	NULL
phosphorylation	NULL
of	NULL
IxBa	NULL
at	NULL
serines	NULL
32	NULL
and	NULL
36	NULL
is	NULL
a	NULL
prerequisite	NULL
for	NULL
proteolytic	NULL
breakdown	NULL
(	NULL
16	NULL
)	NULL
.	NULL

Two	NULL
lines	NULL
of	NULL
experimental	NULL
evidence	NULL
indicate	NULL
that	NULL
a	NULL
related	NULL
posttranslational	NULL
process	NULL
leads	NULL
to	NULL
Tax-mediated	NULL
inactivation	NULL
of	NULL
IxBa	NULL
and	NULL
IxBB	NULL
by	NULL
the	NULL
proteasome	NULL
.	NULL

First	NULL
,	NULL
treatment	NULL
of	NULL
T-cell	NULL
transfectants	NULL
with	NULL
MG132	NULL
,	NULL
a	NULL
peptide	NULL
aldehyde	NULL
inhibitor	NULL
of	NULL
the	NULL
proteasome	NULL
,	NULL
blocks	NULL
Tax-induced	NULL
breakdown	NULL
of	NULL
both	NULL
IxBa	NULL
(	NULL
13	NULL
)	NULL
and	NULL
IxBB	NULL
(	NULL
Fig	NULL
.	NULL

2C	NULL
)	NULL
.	NULL

Degradation	NULL
of	NULL
IBB	NULL
in	NULL
Tax-expressing	NULL
cells	NULL
was	NULL
also	NULL
prevented	NULL
by	NULL
the	NULL
proteasome	NULL
inhibitor	NULL
lactacystin	NULL
(	NULL
Fig	NULL
.	NULL

2D	NULL
)	NULL
,	NULL
which	NULL
exhibits	NULL
a	NULL
more	NULL
restricted	NULL
range	NULL
of	NULL
action	NULL
and	NULL
has	NULL
no	NULL
detectable	NULL
effect	NULL
on	NULL
calpain	NULL
or	NULL
cathepsin	NULL
B	NULL
(	NULL
21	NULL
)	NULL
.	NULL

Second	NULL
,	NULL
by	NULL
analogy	NULL
with	NULL
IxBa	NULL
(	NULL
13	NULL
)	NULL
,	NULL
disruption	NULL
of	NULL
two	NULL
conserved	NULL
serine	NULL
residues	NULL
positioned	NULL
within	NULL
the	NULL
amino	NULL
terminus	NULL
of	NULL
IxBB	NULL
yields	NULL
a	NULL
dominant-negative	NULL
inhibitor	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
that	NULL
is	NULL
resistant	NULL
to	NULL
proteolytic	NULL
breakdown	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
Tax	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
)	NULL
.	NULL

Taken	NULL
together	NULL
,	NULL
these	NULL
findings	NULL
suggest	NULL
that	NULL
HTLV-1	NULL
Tax	NULL
mimics	NULL
extracellular	NULL
immune	NULL
signals	NULL
which	NULL
target	NULL
IxB	NULL
proteins	NULL
to	NULL
the	NULL
proteasome	NULL
,	NULL
including	NULL
those	NULL
mediated	NULL
by	NULL
cytokine	NULL
and	NULL
antigen	NULL
receptors	NULL
(	NULL
13	NULL
,	NULL
14	NULL
,	NULL
16	NULL
,	NULL
62	NULL
,	NULL
78	NULL
,	NULL
79	NULL
)	NULL
.	NULL

The	NULL
mechanism	NULL
by	NULL
which	NULL
Tax	NULL
accesses	NULL
these	NULL
host	NULL
signaling	NULL
pathways	NULL
for	NULL
IxB	NULL
inactivation	NULL
remains	NULL
elusive	NULL
.	NULL

Given	NULL
the	NULL
recent	NULL
finding	NULL
that	NULL
Tax	NULL
forms	NULL
stable	NULL
complexes	NULL
with	NULL
IxBa	NULL
when	NULL
overexpressed	NULL
in	NULL
vivo	NULL
(	NULL
33	NULL
,	NULL
74	NULL
)	NULL
,	NULL
it	NULL
is	NULL
possible	NULL
that	NULL
this	NULL
viral	NULL
protein	NULL
initiates	NULL
the	NULL
process	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
induction	NULL
by	NULL
physically	NULL
dissociating	NULL
IxB	NULL
proteins	NULL
from	NULL
latent	NULL
cytoplasmic	NULL
complexes	NULL
.	NULL

Indeed	NULL
,	NULL
since	NULL
free	NULL
IxBa	NULL
is	NULL
rapidly	NULL
degraded	NULL
(	NULL
73	NULL
)	NULL
,	NULL
this	NULL
model	NULL
could	NULL
potentially	NULL
explain	NULL
the	NULL
mechanism	NULL
by	NULL
which	NULL
Tax	NULL
stimulates	NULL
IxB	NULL
turnover	NULL
.	NULL

However	NULL
,	NULL
we	NULL
have	NULL
observed	NULL
that	NULL
the	NULL
Tax	NULL
Mor	NULL
.	NULL

CELL	NULL
.	NULL

BioL	NULL
.	NULL

M22	NULL
mutant	NULL
,	NULL
which	NULL
is	NULL
defective	NULL
for	NULL
NF-kB	NULL
induction	NULL
(	NULL
68	NULL
)	NULL
and	NULL
IxBa	NULL
breakdown	NULL
(	NULL
13	NULL
)	NULL
,	NULL
retains	NULL
the	NULL
capacity	NULL
to	NULL
bind	NULL
IxBa	NULL
in	NULL
transfected	NULL
cells	NULL
.	NULL

In	NULL
addition	NULL
wild-type	NULL
Tax	NULL
is	NULL
fully	NULL
competent	NULL
to	NULL
form	NULL
stable	NULL
complexes	NULL
with	NULL
dominant-negative	NULL
forms	NULL
of	NULL
IxBa	NULL
that	NULL
escape	NULL
from	NULL
Tax-dependent	NULL
proteolysis	NULL
in	NULL
vivo	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Assuming	NULL
the	NULL
interaction	NULL
is	NULL
physiologically	NULL
rele-vant	NULL
,	NULL
these	NULL
findings	NULL
suggest	NULL
that	NULL
Tax	NULL
binding	NULL
to	NULL
IxBa	NULL
is	NULL
not	NULL
sufficient	NULL
to	NULL
target	NULL
the	NULL
inhibitor	NULL
to	NULL
the	NULL
proteasome	NULL
.	NULL

An	NULL
alternative	NULL
view	NULL
is	NULL
that	NULL
Tax	NULL
regulates	NULL
the	NULL
turnover	NULL
of	NULL
IxB	NULL
proteins	NULL
by	NULL
influencing	NULL
the	NULL
phosphorylation	NULL
status	NULL
of	NULL
serine	NULL
residues	NULL
positioned	NULL
within	NULL
their	NULL
N-terminal	NULL
regions	NULL
.	NULL

In	NULL
light	NULL
of	NULL
emerging	NULL
evidence	NULL
that	NULL
Tax	NULL
and	NULL
immune	NULL
activation	NULL
signals	NULL
converge	NULL
on	NULL
the	NULL
same	NULL
phosphoryl	NULL
group	NULL
acceptors	NULL
within	NULL
IB	NULL
(	NULL
13	NULL
,	NULL
14	NULL
,	NULL
78	NULL
)	NULL
,	NULL
this	NULL
coupling	NULL
mechanism	NULL
may	NULL
involve	NULL
the	NULL
action	NULL
of	NULL
a	NULL
common	NULL
protein	NULL
kinase	NULL
(	NULL
s	NULL
)	NULL
.	NULL

Consistent	NULL
with	NULL
this	NULL
proposal	NULL
,	NULL
antioxi-dants	NULL
that	NULL
prevent	NULL
signal-dependent	NULL
phosphorylation	NULL
of	NULL
IxBa	NULL
in	NULL
response	NULL
to	NULL
normal	NULL
physiologic	NULL
cues	NULL
also	NULL
inhibit	NULL
Tax-mediated	NULL
induction	NULL
of	NULL
NF-kB	NULL
(	NULL
64	NULL
,	NULL
65	NULL
,	NULL
79	NULL
)	NULL
.	NULL

However	NULL
,	NULL
we	NULL
can	NULL
not	NULL
exclude	NULL
the	NULL
possibility	NULL
that	NULL
this	NULL
modification	NULL
step	NULL
is	NULL
dependent	NULL
on	NULL
the	NULL
formation	NULL
of	NULL
IxB-Tax	NULL
complexes	NULL
.	NULL

Despite	NULL
the	NULL
destabilizing	NULL
effects	NULL
of	NULL
Tax	NULL
on	NULL
both	NULL
IxBa	NULL
and	NULL
IxBB	NULL
at	NULL
the	NULL
protein	NULL
level	NULL
,	NULL
this	NULL
viral	NULL
pathway	NULL
for	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
diverges	NULL
downstream	NULL
of	NULL
IxB	NULL
degradation	NULL
at	NULL
the	NULL
transcription	NULL
level	NULL
,	NULL
resulting	NULL
in	NULL
NF-	NULL
«	NULL
B-directed	NULL
synthesis	NULL
of	NULL
IxBa	NULL
but	NULL
not	NULL
IBB	NULL
(	NULL
Fig	NULL
.	NULL

6	NULL
)	NULL
.	NULL

In	NULL
HTLV-1-infected	NULL
T	NULL
lymphocytes	NULL
,	NULL
the	NULL
capacity	NULL
of	NULL
Tax	NULL
to	NULL
inactivate	NULL
IxBB	NULL
without	NULL
stimulating	NULL
transcription	NULL
of	NULL
the	NULL
corresponding	NULL
gene	NULL
culminates	NULL
in	NULL
the	NULL
chronic	NULL
downregulation	NULL
of	NULL
IxBB	NULL
protein	NULL
expression	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
the	NULL
cytoplasmic	NULL
pool	NULL
of	NULL
IxBa	NULL
«	NULL
is	NULL
maintained	NULL
by	NULL
de	NULL
novo	NULL
protein	NULL
synthesis	NULL
in	NULL
response	NULL
to	NULL
NF-KB	NULL
activation	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
and	NULL
5	NULL
)	NULL
.	NULL

This	NULL
pattern	NULL
of	NULL
IxB	NULL
expression	NULL
,	NULL
coupled	NULL
with	NULL
the	NULL
tonic	NULL
inducing	NULL
action	NULL
of	NULL
HTLV-1	NULL
Tax	NULL
,	NULL
may	NULL
account	NULL
for	NULL
the	NULL
persistent	NULL
NF-	NULL
«	NULL
B	NULL
response	NULL
in	NULL
virally	NULL
infected	NULL
cells	NULL
.	NULL

In	NULL
this	NULL
regard	NULL
,	NULL
Thompson	NULL
et	NULL
al	NULL
.	NULL

recently	NULL
reported	NULL
that	NULL
IxBfB	NULL
inactivation	NULL
is	NULL
tightly	NULL
associated	NULL
with	NULL
nonviral	NULL
agents	NULL
that	NULL
induce	NULL
a	NULL
persistent	NULL
NF-kB	NULL
response	NULL
,	NULL
such	NULL
as	NULL
LPS	NULL
and	NULL
IL-1	NULL
(	NULL
77	NULL
)	NULL
.	NULL

In	NULL
cells	NULL
treated	NULL
with	NULL
either	NULL
of	NULL
these	NULL
extracellular	NULL
inducers	NULL
,	NULL
both	NULL
IxBa	NULL
and	NULL
IxBB	NULL
are	NULL
rapidly	NULL
de-graded	NULL
,	NULL
but	NULL
only	NULL
IxBa	NULL
reaccumulates	NULL
in	NULL
the	NULL
cytoplasm	NULL
following	NULL
NF-kB	NULL
induction	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
IxBa	NULL
appears	NULL
to	NULL
be	NULL
selectively	NULL
degraded	NULL
in	NULL
cells	NULL
treated	NULL
with	NULL
tumor	NULL
necrosis	NULL
factor	NULL
alpha	NULL
or	NULL
phorbol	NULL
esters	NULL
,	NULL
both	NULL
of	NULL
which	NULL
elicit	NULL
a	NULL
transient	NULL
NF-	NULL
«	NULL
B	NULL
response	NULL
(	NULL
77	NULL
)	NULL
.	NULL

These	NULL
findings	NULL
collectively	NULL
suggest	NULL
that	NULL
IxBB	NULL
plays	NULL
a	NULL
significant	NULL
role	NULL
in	NULL
regulating	NULL
the	NULL
duration	NULL
of	NULL
NF-kB	NULL
activity	NULL
in	NULL
the	NULL
nuclear	NULL
compartment	NULL
.	NULL

Why	NULL
might	NULL
inactivation	NULL
of	NULL
IxBB	NULL
be	NULL
required	NULL
for	NULL
the	NULL
development	NULL
of	NULL
a	NULL
chronic	NULL
NF-kB	NULL
response	NULL
?	NULL

One	NULL
possibility	NULL
is	NULL
that	NULL
IxBB-bound	NULL
NF-	NULL
«	NULL
B	NULL
is	NULL
uniquely	NULL
endowed	NULL
for	NULL
persistent	NULL
nuclear	NULL
expression	NULL
.	NULL

For	NULL
example	NULL
,	NULL
following	NULL
its	NULL
release	NULL
from	NULL
IBB	NULL
,	NULL
NF-	NULL
«	NULL
B	NULL
may	NULL
be	NULL
refractory	NULL
to	NULL
postinduction	NULL
repression	NULL
mediated	NULL
by	NULL
newly	NULL
synthesized	NULL
IxBa	NULL
(	NULL
22	NULL
,	NULL
77	NULL
)	NULL
.	NULL

Alternatively	NULL
,	NULL
the	NULL
findings	NULL
presented	NULL
here	NULL
may	NULL
reflect	NULL
the	NULL
requirement	NULL
for	NULL
a	NULL
threshold	NULL
level	NULL
of	NULL
cytoplasmic	NULL
IxB	NULL
to	NULL
fully	NULL
inhibit	NULL
NF-	NULL
«	NULL
B	NULL
.	NULL

While	NULL
IxB	NULL
expression	NULL
is	NULL
downregulated	NULL
in	NULL
HTLV-1-infected	NULL
lymphocytes	NULL
,	NULL
the	NULL
concentration	NULL
of	NULL
certain	NULL
Rel	NULL
subunits	NULL
is	NULL
elevated	NULL
as	NULL
a	NULL
result	NULL
of	NULL
NF-	NULL
«	NULL
B-directed	NULL
transcription	NULL
of	NULL
the	NULL
corresponding	NULL
genes	NULL
(	NULL
37	NULL
,	NULL
72	NULL
,	NULL
76	NULL
)	NULL
.	NULL

As	NULL
a	NULL
consequence	NULL
of	NULL
this	NULL
stoichiometric	NULL
imbal-ance	NULL
,	NULL
the	NULL
total	NULL
intracellular	NULL
concentration	NULL
of	NULL
IxB	NULL
may	NULL
be	NULL
insufficient	NULL
to	NULL
sequester	NULL
NF-	NULL
«	NULL
B	NULL
in	NULL
the	NULL
cytoplasmic	NULL
compartment	NULL
of	NULL
Tax-expressing	NULL
cells	NULL
.	NULL

The	NULL
proteasome	NULL
is	NULL
rapidly	NULL
emerging	NULL
as	NULL
a	NULL
key	NULL
regulator	NULL
of	NULL
transcription	NULL
factors	NULL
involved	NULL
in	NULL
the	NULL
control	NULL
of	NULL
normal	NULL
cellular	NULL
growth	NULL
.	NULL

In	NULL
addition	NULL
to	NULL
IB	NULL
proteins	NULL
(	NULL
22	NULL
)	NULL
,	NULL
proteasome-dependent	NULL
turnover	NULL
of	NULL
the	NULL
c-jun	NULL
proto-oncogene	NULL
product	NULL
appears	NULL
to	NULL
play	NULL
a	NULL
pivotal	NULL
role	NULL
in	NULL
governing	NULL
its	NULL
transcriptional	NULL
activity	NULL
(	NULL
80	NULL
)	NULL
.	NULL

Furthermore	NULL
,	NULL
recent	NULL
studies	NULL
suggest	NULL
that	NULL
human	NULL
papillomavirus	NULL
types	NULL
16	NULL
and	NULL
18	NULL
promote	NULL
cellular	NULL
transformation	NULL
by	NULL
stim-	NULL
Vou	NULL
.	NULL

16	NULL
,	NULL
1996	NULL
ulating	NULL
proteasome-mediated	NULL
breakdown	NULL
of	NULL
the	NULL
p53	NULL
tumor	NULL
suppressor	NULL
(	NULL
61	NULL
)	NULL
.	NULL

It	NULL
is	NULL
now	NULL
evident	NULL
that	NULL
HTLV-1	NULL
also	NULL
employs	NULL
the	NULL
proteasome	NULL
to	NULL
constitutively	NULL
activate	NULL
NF-kB	NULL
in	NULL
CD4*	NULL
T	NULL
lymphocytes	NULL
,	NULL
resulting	NULL
in	NULL
the	NULL
abnormal	NULL
expression	NULL
of	NULL
select	NULL
genes	NULL
involved	NULL
in	NULL
growth-signal	NULL
transduction	NULL
(	NULL
27	NULL
)	NULL
.	NULL

Our	NULL
prior	NULL
findings	NULL
(	NULL
13	NULL
,	NULL
62	NULL
)	NULL
and	NULL
the	NULL
results	NULL
presented	NULL
here	NULL
suggest	NULL
that	NULL
this	NULL
mechanism	NULL
involves	NULL
the	NULL
unique	NULL
capacity	NULL
of	NULL
the	NULL
HTLV-1	NULL
Tax	NULL
protein	NULL
to	NULL
convert	NULL
both	NULL
IxBa	NULL
and	NULL
IxBB	NULL
into	NULL
labile	NULL
proteasome	NULL
substrates	NULL
.	NULL

Future	NULL
studies	NULL
to	NULL
define	NULL
precisely	NULL
how	NULL
Tax	NULL
executes	NULL
this	NULL
IxB	NULL
targeting	NULL
function	NULL
may	NULL
illuminate	NULL
novel	NULL
strategies	NULL
for	NULL
therapeutic	NULL
control	NULL
of	NULL
HTLV-1-associated	NULL
diseases	NULL
.	NULL

ACKNOWLEDGMENTS	NULL
We	NULL
thank	NULL
the	NULL
NIH/NIAID	NULL
AIDS	NULL
Repository	NULL
for	NULL
providing	NULL
the	NULL
MT-2	NULL
and	NULL
MT-4	NULL
cell	NULL
lines	NULL
;	NULL
Zhijian	NULL
Chen	NULL
,	NULL
Sankar	NULL
Ghosh	NULL
,	NULL
Warner	NULL
Greene	NULL
,	NULL
Albert	NULL
Baldwin	NULL
,	NULL
John	NULL
Brady	NULL
,	NULL
and	NULL
Craig	NULL
Rosen	NULL
for	NULL
reagents	NULL
;	NULL
Xiaoxia	NULL
Qi	NULL
and	NULL
Hong	NULL
Zhang	NULL
for	NULL
technical	NULL
assistance	NULL
;	NULL
Earl	NULL
Ruley	NULL
and	NULL
Luc	NULL
Van	NULL
Kaer	NULL
for	NULL
critical	NULL
comments	NULL
;	NULL
and	NULL
Emily	NULL
Vance	NULL
for	NULL
manuscript	NULL
prepa-ration	NULL
.	NULL

This	NULL
study	NULL
was	NULL
supported	NULL
by	NULL
the	NULL
Howard	NULL
Hughes	NULL
Medical	NULL
Institute	NULL
,	NULL
grant	NULL
RO1	NULL
AI33839	NULL
from	NULL
the	NULL
National	NULL
Institute	NULL
of	NULL
Allergy	NULL
and	NULL
Infectious	NULL
Diseases	NULL
(	NULL
to	NULL
D.W.B	NULL
.	NULL
)	NULL

,	NULL
and	NULL
grants	NULL
from	NULL
the	NULL
National	NULL
Institutes	NULL
of	NULL
Health	NULL
(	NULL
CA5958-01	NULL
)	NULL
,	NULL
Leukemia	NULL
Society	NULL
of	NULL
America	NULL
,	NULL
and	NULL
the	NULL
Mellon	NULL
Foundation	NULL
(	NULL
to	NULL
P.LG	NULL
.	NULL
)	NULL

.	NULL

P.L.G	NULL
.	NULL

is	NULL
a	NULL
Leukemia	NULL
Society	NULL
of	NULL
America	NULL
Scholar	NULL
.	NULL

REFERENCES	NULL
1	NULL
.	NULL

Andersson	NULL
,	NULL
S.	NULL
,	NULL
D.	NULL
L.	NULL
Davis	NULL
,	NULL
H.	NULL
Dahlback	NULL
,	NULL
H.	NULL
Jornvall	NULL
,	NULL
and	NULL
D.	NULL
W.	NULL
Russell	NULL
.	NULL

1989	NULL
.	NULL

Cloning	NULL
,	NULL
structure	NULL
,	NULL
and	NULL
expression	NULL
of	NULL
the	NULL
mitochondrial	NULL
cytochrome	NULL
P-450	NULL
sterol	NULL
26-hydroxylase	NULL
,	NULL
a	NULL
bile	NULL
acid	NULL
biosynthetic	NULL
enzyme	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

264:8222-8229	NULL
.	NULL

2	NULL
.	NULL

Baeuerle	NULL
,	NULL
P.	NULL
,	NULL
and	NULL
D.	NULL
Baltimore	NULL
.	NULL

1988	NULL
.	NULL

Activation	NULL
of	NULL
DNA-binding	NULL
activity	NULL
in	NULL
an	NULL
apparently	NULL
cytoplasmic	NULL
precursor	NULL
of	NULL
the	NULL
NF-B	NULL
transcription	NULL
factor	NULL
.	NULL

Cell	NULL
53:211-217	NULL
.	NULL

3	NULL
.	NULL

Baeuerle	NULL
,	NULL
P.	NULL
,	NULL
and	NULL
D.	NULL
Baltimore	NULL
.	NULL

1988	NULL
.	NULL

IxB	NULL
:	NULL
a	NULL
specific	NULL
inhibitor	NULL
of	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
transcription	NULL
factor	NULL
.	NULL

Science	NULL
242:540-546	NULL
.	NULL

4	NULL
.	NULL

Baeuerle	NULL
,	NULL
P.	NULL
,	NULL
and	NULL
D.	NULL
Baltimore	NULL
.	NULL

1989	NULL
.	NULL

A	NULL
65-kD	NULL
subunit	NULL
of	NULL
active	NULL
NF-	NULL
«	NULL
B	NULL
is	NULL
required	NULL
for	NULL
inhibition	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
by	NULL
IxB	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

3:1689-1698	NULL
.	NULL

5	NULL
.	NULL

Ballard	NULL
,	NULL
D.	NULL
W.	NULL
,	NULL
E.	NULL
Bohnlein	NULL
,	NULL
J.	NULL
W.	NULL
Lowenthal	NULL
,	NULL
Y.	NULL
Wano	NULL
,	NULL
B.	NULL
R.	NULL
Franza	NULL
,	NULL
and	NULL
W.	NULL
C.	NULL
Greene	NULL
.	NULL

1988	NULL
.	NULL

HTLV-I	NULL
Tax	NULL
induces	NULL
cellular	NULL
proteins	NULL
that	NULL
activate	NULL
the	NULL
xB	NULL
clement	NULL
in	NULL
the	NULL
IL-2	NULL
receptor	NULL
«	NULL
gene	NULL
.	NULL

Science	NULL
241:1652-1655	NULL
.	NULL

6	NULL
.	NULL

Ballard	NULL
,	NULL
D.	NULL
W.	NULL
,	NULL
E.	NULL
P.	NULL
Dixon	NULL
,	NULL
N.	NULL
J.	NULL
Peffer	NULL
,	NULL
H.	NULL
Bogerd	NULL
,	NULL
S.	NULL
Doerre	NULL
,	NULL
B.	NULL
Stein	NULL
,	NULL
and	NULL
W.	NULL
C.	NULL
Greene	NULL
.	NULL

1992	NULL
.	NULL

The	NULL
65-kDa	NULL
subunit	NULL
of	NULL
human	NULL
NF-	NULL
«	NULL
B	NULL
functions	NULL
as	NULL
a	NULL
potent	NULL
transcriptional	NULL
activator	NULL
and	NULL
a	NULL
target	NULL
for	NULL
v-Rel-mediated	NULL
repression	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
89:1875-1879	NULL
.	NULL

7	NULL
.	NULL

Ballard	NULL
,	NULL
D.	NULL
W.	NULL
,	NULL
W.	NULL
H.	NULL
Walker	NULL
,	NULL
S.	NULL
Doerre	NULL
,	NULL
P.	NULL
Sista	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
Molitor	NULL
,	NULL
E.	NULL
P.	NULL
Dixon	NULL
,	NULL
N.	NULL
J.	NULL
Peffer	NULL
,	NULL
M.	NULL
Hannink	NULL
,	NULL
and	NULL
W.	NULL
C.	NULL
Greene	NULL
.	NULL

1990	NULL
.	NULL

The	NULL
v-rel	NULL
oncogene	NULL
encodes	NULL
a	NULL
xB	NULL
enhancer	NULL
binding	NULL
protein	NULL
that	NULL
inhibits	NULL
NF-	NULL
«	NULL
B	NULL
function	NULL
.	NULL

Cell	NULL
63:803-814	NULL
.	NULL

8	NULL
.	NULL

Beg	NULL
,	NULL
A	NULL
.	NULL

A.	NULL
,	NULL
T.	NULL
S.	NULL
Finco	NULL
,	NULL
P.	NULL
V.	NULL
Nantermet	NULL
,	NULL
and	NULL
A.	NULL
S.	NULL
Baldwin	NULL
,	NULL
Jr.	NULL
1993	NULL
.	NULL

Tumor	NULL
necrosis	NULL
factor	NULL
and	NULL
interleukin-1	NULL
lead	NULL
to	NULL
phosphorylation	NULL
and	NULL
loss	NULL
of	NULL
IxBa	NULL
:	NULL
a	NULL
mechanism	NULL
for	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

13:3301-3310	NULL
.	NULL

9	NULL
.	NULL

Beg	NULL
,	NULL
A	NULL
.	NULL

A.	NULL
,	NULL
S.	NULL
M.	NULL
Ruben	NULL
,	NULL
R.	NULL
I.	NULL
Scheinman	NULL
,	NULL
S.	NULL
Haskill	NULL
,	NULL
C.	NULL
A.	NULL
Rosen	NULL
,	NULL
and	NULL
A.	NULL
S.	NULL
Baldwin	NULL
,	NULL
Jr.	NULL
1992	NULL
.	NULL

IxB	NULL
interacts	NULL
with	NULL
the	NULL
nuclear	NULL
localization	NULL
sequences	NULL
of	NULL
the	NULL
subunits	NULL
of	NULL
NF-B	NULL
:	NULL
a	NULL
mechanism	NULL
for	NULL
cytoplasm	NULL
retention	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

6:1899-1913	NULL
.	NULL

10	NULL
.	NULL

Béraud	NULL
,	NULL
C.	NULL
,	NULL
S.-C.	NULL
Sun	NULL
,	NULL
P.	NULL
Ganchi	NULL
,	NULL
D.	NULL
W.	NULL
Ballard	NULL
,	NULL
and	NULL
W.	NULL
C.	NULL
Greene	NULL
.	NULL

1994	NULL
.	NULL

Human	NULL
T-cell	NULL
leukemia	NULL
virus	NULL
type	NULL
I	NULL
Tax	NULL
associates	NULL
with	NULL
and	NULL
is	NULL
negatively	NULL
regulated	NULL
by	NULL
the	NULL
NF-	NULL
«	NULL
xB2	NULL
p100	NULL
gene	NULL
product	NULL
:	NULL
implications	NULL
for	NULL
viral	NULL
latency	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

14:1374-1382	NULL
.	NULL

11	NULL
.	NULL

Blanar	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
W.	NULL
J.	NULL
Rutter	NULL
.	NULL

1992	NULL
.	NULL

Interaction	NULL
cloning	NULL
:	NULL
identification	NULL
of	NULL
a	NULL
helix-loop-helix	NULL
zipper	NULL
protein	NULL
that	NULL
interacts	NULL
with	NULL
c-fos	NULL
.	NULL

Science	NULL
256:1014-1018	NULL
.	NULL

12	NULL
.	NULL

Bours	NULL
,	NULL
V.	NULL
,	NULL
J.	NULL
Villalobos	NULL
,	NULL
P.	NULL
R.	NULL
Burd	NULL
,	NULL
K.	NULL
Kelly	NULL
,	NULL
and	NULL
U.	NULL
Siebenlist	NULL
.	NULL

1990	NULL
.	NULL

Cloning	NULL
of	NULL
a	NULL
mitogen-inducible	NULL
gene	NULL
encoding	NULL
a	NULL
«	NULL
B	NULL
DNA-binding	NULL
protein	NULL
with	NULL
homology	NULL
to	NULL
the	NULL
ref	NULL
oncogene	NULL
and	NULL
to	NULL
cell-cycle	NULL
motifs	NULL
.	NULL

Nature	NULL
(	NULL
London	NULL
)	NULL
348:76-80	NULL
.	NULL

13	NULL
.	NULL

Brockman	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
,	NULL
D.	NULL
C.	NULL
Scherer	NULL
,	NULL
T.	NULL
A.	NULL
McKinsey	NULL
,	NULL
S.	NULL
M.	NULL
Hall	NULL
,	NULL
X.	NULL
Qi	NULL
,	NULL
W.	NULL
Y.	NULL
Lee	NULL
,	NULL
and	NULL
D.	NULL
W.	NULL
Ballard	NULL
.	NULL

1995	NULL
.	NULL

Coupling	NULL
of	NULL
a	NULL
signal-response	NULL
domain	NULL
in	NULL
IxBa	NULL
to	NULL
multiple	NULL
pathways	NULL
for	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

15:2809-2818	NULL
.	NULL

14	NULL
.	NULL

Brown	NULL
,	NULL
K.	NULL
,	NULL
S.	NULL
Gerstberger	NULL
,	NULL
L.	NULL
Carlson	NULL
,	NULL
G.	NULL
Franzoso	NULL
,	NULL
and	NULL
U.	NULL
Siebenlist	NULL
.	NULL

1995	NULL
.	NULL

Control	NULL
of	NULL
IxB-a	NULL
proteolysis	NULL
by	NULL
site-specific	NULL
,	NULL
signal-induced	NULL
phosphorylation	NULL
.	NULL

Science	NULL
267:1485-1488	NULL
.	NULL

15	NULL
.	NULL

Brown	NULL
,	NULL
K.	NULL
,	NULL
S.	NULL
Park	NULL
,	NULL
T.	NULL
Kanno	NULL
,	NULL
G.	NULL
Franzoso	NULL
,	NULL
and	NULL
U.	NULL
Siebenlist	NULL
.	NULL

1993	NULL
.	NULL

Mutual	NULL
regulation	NULL
of	NULL
the	NULL
transcriptional	NULL
activator	NULL
NF-	NULL
«	NULL
B	NULL
and	NULL
its	NULL
inhibitor	NULL
,	NULL
I	NULL
«	NULL
Be	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
90:2532-2536	NULL
.	NULL

16	NULL
.	NULL

17	NULL
.	NULL

18	NULL
.	NULL

19	NULL
.	NULL

20	NULL
.	NULL

21	NULL
.	NULL

22	NULL
.	NULL

23	NULL
.	NULL

24	NULL
.	NULL

26	NULL
.	NULL

27	NULL
.	NULL

28	NULL
.	NULL

29	NULL
.	NULL

30	NULL
.	NULL

31	NULL
.	NULL

32	NULL
.	NULL

33	NULL
.	NULL

34	NULL
.	NULL

35	NULL
.	NULL

36	NULL
.	NULL

37	NULL
.	NULL

38	NULL
.	NULL

39	NULL
.	NULL

40	NULL
.	NULL

41	NULL
.	NULL

DEREGULATION	NULL
OF	NULL
IkBB	NULL
BY	NULL
HTLV-1	NULL
Tax	NULL
2089	NULL
Chen	NULL
,	NULL
Z.	NULL
,	NULL
J.	NULL
Hagler	NULL
,	NULL
V.	NULL
J.	NULL
Palombella	NULL
,	NULL
F.	NULL
Melandri	NULL
,	NULL
D.	NULL
Scherer	NULL
,	NULL
D.	NULL
Ballard	NULL
,	NULL
and	NULL
T.	NULL
Maniatis	NULL
.	NULL

1995	NULL
.	NULL

Signal-induced	NULL
site-specific	NULL
phosphorylation	NULL
targets	NULL
IxBa	NULL
to	NULL
the	NULL
ubiquitin-proteasome	NULL
pathway	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

9:1586-1597	NULL
.	NULL

Chiao	NULL
,	NULL
P.	NULL
J.	NULL
,	NULL
S.	NULL
Miyamoto	NULL
,	NULL
and	NULL
I.	NULL
M.	NULL
Verma	NULL
.	NULL

1994	NULL
.	NULL

Autoregulation	NULL
of	NULL
IxBa	NULL
activity	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
91:28-32	NULL
.	NULL

Chomczynski	NULL
,	NULL
P.	NULL
,	NULL
and	NULL
N.	NULL
Sacchi	NULL
.	NULL

1991	NULL
.	NULL

Single-step	NULL
RNA	NULL
isolation	NULL
from	NULL
cultured	NULL
cells	NULL
or	NULL
tissues	NULL
,	NULL
p.	NULL
4.2.4-4.2.8	NULL
.	NULL

In	NULL
F.	NULL
M.	NULL
Ausubel	NULL
,	NULL
R.	NULL
Brent	NULL
,	NULL
R.	NULL
E.	NULL
Kingston	NULL
,	NULL
D.	NULL
D.	NULL
Moore	NULL
,	NULL
J.	NULL
G.	NULL
Seidman	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
Smith	NULL
,	NULL
and	NULL
K.	NULL
Strubl	NULL
(	NULL
ed	NULL
.	NULL
)	NULL

,	NULL
Current	NULL
protocols	NULL
in	NULL
molecular	NULL
biology	NULL
.	NULL

John	NULL
Wiley	NULL
&	NULL
Sons	NULL
,	NULL
Inc.	NULL
,	NULL
New	NULL
York	NULL
.	NULL

Cross	NULL
,	NULL
S.	NULL
L.	NULL
,	NULL
M.	NULL
B.	NULL
Feinberg	NULL
,	NULL
J	NULL
.	NULL

B.	NULL
Wolf	NULL
,	NULL
N.	NULL
J.	NULL
Holbrook	NULL
,	NULL
F.	NULL
Wong-Staal	NULL
,	NULL
and	NULL
W.	NULL
J.	NULL
Leonard	NULL
.	NULL

1987	NULL
.	NULL

Regulation	NULL
of	NULL
the	NULL
human	NULL
interleukin-2	NULL
receptor	NULL
«	NULL
chain	NULL
promoter	NULL
:	NULL
activation	NULL
of	NULL
a	NULL
nonfunctional	NULL
promoter	NULL
by	NULL
the	NULL
transactivator	NULL
gene	NULL
of	NULL
HTLV-I	NULL
.	NULL

Cell	NULL
49:47-56.	NULL
deMartin	NULL
,	NULL
R.	NULL
,	NULL
B.	NULL
Vanhove	NULL
,	NULL
Q.	NULL
Cheng	NULL
,	NULL
E.	NULL
Hofer	NULL
,	NULL
V.	NULL
Csizmadia	NULL
,	NULL
H.	NULL
Winkler	NULL
,	NULL
and	NULL
F.	NULL
H.	NULL
Bach	NULL
.	NULL

1993	NULL
.	NULL

Cytokine-inducible	NULL
expression	NULL
in	NULL
endothelial	NULL
cells	NULL
of	NULL
an	NULL
IxBa-like	NULL
gene	NULL
is	NULL
regulated	NULL
by	NULL
NF-kB	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

12:2773-2779	NULL
.	NULL

Fenteany	NULL
,	NULL
G.	NULL
,	NULL
R.	NULL
F.	NULL
Standaert	NULL
,	NULL
W.	NULL
S.	NULL
Lane	NULL
,	NULL
S.	NULL
Choi	NULL
,	NULL
E.	NULL
J.	NULL
Corey	NULL
,	NULL
and	NULL
S.	NULL
L.	NULL
Schreiber	NULL
.	NULL

1995	NULL
.	NULL

Inhibition	NULL
of	NULL
proteasome	NULL
activities	NULL
and	NULL
subunit-specific	NULL
ami-no-terminal	NULL
threonine	NULL
modification	NULL
by	NULL
lactacystin	NULL
.	NULL

Science	NULL
268:726-731	NULL
.	NULL

Finco	NULL
,	NULL
T.	NULL
,	NULL
and	NULL
A.	NULL
S.	NULL
Baldwin	NULL
.	NULL

1995	NULL
.	NULL

Mechanistic	NULL
aspects	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
regulation	NULL
:	NULL
the	NULL
emerging	NULL
role	NULL
of	NULL
phosphorylation	NULL
and	NULL
proteolysis	NULL
.	NULL

Immunity	NULL
3:263-272	NULL
.	NULL

Ganchi	NULL
,	NULL
P.	NULL
,	NULL
S.-C.	NULL
Sun	NULL
,	NULL
W.	NULL
C.	NULL
Greene	NULL
,	NULL
and	NULL
D.	NULL
W.	NULL
Ballard	NULL
.	NULL

1992	NULL
.	NULL

IxB/MAD-3	NULL
masks	NULL
the	NULL
nuclear	NULL
localization	NULL
signal	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
p65	NULL
and	NULL
requires	NULL
the	NULL
transactivation	NULL
domain	NULL
to	NULL
inhibit	NULL
NF-kB	NULL
p65	NULL
DNA	NULL
binding	NULL
.	NULL

Mol	NULL
.	NULL

Biol	NULL
.	NULL

Cell	NULL
3:1339-1352	NULL
.	NULL

Gause	NULL
,	NULL
W.	NULL
C.	NULL
,	NULL
and	NULL
J.	NULL
Adamoviez	NULL
.	NULL

1995	NULL
.	NULL

Use	NULL
of	NULL
PCR	NULL
to	NULL
quantitate	NULL
relative	NULL
differences	NULL
in	NULL
gene	NULL
expression	NULL
,	NULL
p.	NULL
293-311	NULL
.	NULL

In	NULL
C.	NULL
W.	NULL
Diffenbach	NULL
and	NULL
G.	NULL
S.	NULL
Dveksler	NULL
(	NULL
ed	NULL
.	NULL
)	NULL

,	NULL
PCR	NULL
primer	NULL
.	NULL

Cold	NULL
Spring	NULL
Harbor	NULL
Laboratory	NULL
Press	NULL
,	NULL
Cold	NULL
Spring	NULL
Harbor	NULL
,	NULL
N.Y.	NULL
.	NULL

Gazdar	NULL
,	NULL
A.	NULL
F.	NULL
,	NULL
D.	NULL
N.	NULL
Carrney	NULL
,	NULL
P.	NULL
A.	NULL
Bunn	NULL
,	NULL
E.	NULL
K.	NULL
Russell	NULL
,	NULL
E.	NULL
S.	NULL
Jaffe	NULL
,	NULL
G.	NULL
P.	NULL
Schechter	NULL
,	NULL
and	NULL
J.	NULL
G.	NULL
Guecion	NULL
.	NULL

1980	NULL
.	NULL

Mitogen	NULL
requirements	NULL
for	NULL
the	NULL
in	NULL
vitro	NULL
propagation	NULL
of	NULL
cutaneous	NULL
T-cell	NULL
lymphomas	NULL
.	NULL

Blood	NULL
55:409-417	NULL
.	NULL

Ghosh	NULL
,	NULL
S.	NULL
,	NULL
A.	NULL
M.	NULL
Gifford	NULL
,	NULL
L.	NULL
R.	NULL
Riviere	NULL
,	NULL
P.	NULL
Tempst	NULL
,	NULL
G.	NULL
P.	NULL
Nolan	NULL
,	NULL
and	NULL
D.	NULL
Baltimore	NULL
.	NULL

1990	NULL
.	NULL

Cloning	NULL
of	NULL
the	NULL
p50	NULL
DNA	NULL
binding	NULL
subunit	NULL
of	NULL
NF-kB	NULL
:	NULL
homology	NULL
to	NULL
re	NULL
?	NULL

and	NULL
dorsal	NULL
.	NULL

Cell	NULL
62:1019-1029	NULL
.	NULL

Greene	NULL
,	NULL
W.	NULL
C.	NULL
,	NULL
E.	NULL
Bohnlein	NULL
,	NULL
and	NULL
D.	NULL
W.	NULL
Ballard	NULL
.	NULL

1989	NULL
.	NULL

HIV-1	NULL
,	NULL
HTLV-1	NULL
and	NULL
normal	NULL
T-cell	NULL
growth	NULL
:	NULL
transcriptional	NULL
strategies	NULL
and	NULL
surprises	NULL
.	NULL

Immunol	NULL
.	NULL

Today	NULL
10:272-277	NULL
.	NULL

Grilli	NULL
,	NULL
M.	NULL
,	NULL
J.	NULL
Chiu	NULL
,	NULL
and	NULL
M.	NULL
Lenardo	NULL
.	NULL

1993	NULL
.	NULL

NF-B	NULL
and	NULL
Rel	NULL
:	NULL
participants	NULL
in	NULL
a	NULL
multiform	NULL
transcriptional	NULL
regulatory	NULL
system	NULL
.	NULL

Int	NULL
.	NULL

Rev	NULL
.	NULL

Cytol	NULL
.	NULL

143:1-62	NULL
.	NULL

Haskill	NULL
,	NULL
S.	NULL
,	NULL
A	NULL
.	NULL

A.	NULL
Beg	NULL
,	NULL
S.	NULL
M.	NULL
Tompkins	NULL
,	NULL
J.	NULL
S.	NULL
Morris	NULL
,	NULL
A.	NULL
D.	NULL
Yurochko	NULL
,	NULL
A.	NULL
Sampson-Johannes	NULL
,	NULL
K.	NULL
Mondal	NULL
,	NULL
P.	NULL
Ralph	NULL
,	NULL
and	NULL
A.	NULL
S.	NULL
Baldwin	NULL
,	NULL
Jr.	NULL
1991	NULL
.	NULL

Characterization	NULL
of	NULL
an	NULL
immediate-carly	NULL
gene	NULL
induced	NULL
in	NULL
adherent	NULL
monocytes	NULL
that	NULL
encodes	NULL
IxB-like	NULL
activity	NULL
.	NULL

Cell	NULL
65:1281-1289	NULL
.	NULL

Henkel	NULL
,	NULL
T.	NULL
,	NULL
T.	NULL
Machleidt	NULL
,	NULL
I.	NULL
Alkalay	NULL
,	NULL
M.	NULL
Kronke	NULL
,	NULL
Y.	NULL
Ben-Neriah	NULL
,	NULL
and	NULL
P.	NULL
Baeuerle	NULL
.	NULL

1993	NULL
.	NULL

Rapid	NULL
proteolysis	NULL
of	NULL
IxB-	NULL
«	NULL
is	NULL
necessary	NULL
in	NULL
the	NULL
activation	NULL
of	NULL
transcription	NULL
factor	NULL
NF-	NULL
«	NULL
B	NULL
.	NULL

Nature	NULL
(	NULL
London	NULL
)	NULL
365:182-185	NULL
.	NULL

Hinrichs	NULL
,	NULL
S.	NULL
H.	NULL
,	NULL
M.	NULL
Nerenberg	NULL
,	NULL
K.	NULL
Reynolds	NULL
,	NULL
G.	NULL
Khoury	NULL
,	NULL
and	NULL
G.	NULL
Jay	NULL
.	NULL

1987	NULL
.	NULL

A	NULL
transgenic	NULL
mouse	NULL
model	NULL
for	NULL
human	NULL
neurofibromatosis	NULL
.	NULL

Science	NULL
237:1340-1343	NULL
.	NULL

Hirai	NULL
,	NULL
H.	NULL
,	NULL
J.	NULL
Fujisawa	NULL
,	NULL
T.	NULL
Suzuki	NULL
,	NULL
K.	NULL
Ueda	NULL
,	NULL
M.	NULL
Muramatsu	NULL
,	NULL
A.	NULL
Tsuboi	NULL
,	NULL
N.	NULL
Arai	NULL
,	NULL
and	NULL
M.	NULL
Yoshida	NULL
.	NULL

1992	NULL
.	NULL

Transcriptional	NULL
activator	NULL
Tax	NULL
of	NULL
HTLV-I	NULL
binds	NULL
to	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
precursor	NULL
p105	NULL
.	NULL

Oncogene	NULL
7:1737-1742	NULL
.	NULL

Hirai	NULL
,	NULL
H.	NULL
,	NULL
T.	NULL
Suzuki	NULL
,	NULL
J.	NULL
Fujisawa	NULL
,	NULL
J.	NULL
Inoue	NULL
,	NULL
and	NULL
M.	NULL
Yoshida	NULL
.	NULL

1994	NULL
.	NULL

Tax	NULL
protein	NULL
of	NULL
human	NULL
T-cell	NULL
leukemia	NULL
virus	NULL
type	NULL
I	NULL
binds	NULL
to	NULL
the	NULL
ankyrin	NULL
motifs	NULL
of	NULL
inhibitory	NULL
factor	NULL
xB	NULL
and	NULL
induces	NULL
nuclear	NULL
translocation	NULL
of	NULL
transcription	NULL
factor	NULL
NF-	NULL
«	NULL
B	NULL
proteins	NULL
for	NULL
transcriptional	NULL
activation	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
91:3584-3588	NULL
.	NULL

Holbrook	NULL
,	NULL
N.	NULL
,	NULL
A.	NULL
Gulino	NULL
,	NULL
and	NULL
F.	NULL
Ruscetti	NULL
.	NULL

1987	NULL
.	NULL

Cis-acting	NULL
transcriptional	NULL
regulatory	NULL
sequences	NULL
in	NULL
the	NULL
gibbon	NULL
ape	NULL
leukemia	NULL
virus	NULL
(	NULL
GALV	NULL
)	NULL
long	NULL
terminal	NULL
repeat	NULL
.	NULL

Virology	NULL
157:211-219	NULL
.	NULL

Inoue	NULL
,	NULL
J.-L.	NULL
,	NULL
M.	NULL
Seiki	NULL
,	NULL
T.	NULL
Taniguchi	NULL
,	NULL
S.	NULL
Tsuru	NULL
,	NULL
and	NULL
M.	NULL
Yoshida	NULL
.	NULL

1986	NULL
.	NULL

Induction	NULL
of	NULL
interleukin-2	NULL
receptor	NULL
gene	NULL
expression	NULL
by	NULL
p40*	NULL
encoded	NULL
by	NULL
human	NULL
T-cell	NULL
leukemia	NULL
virus	NULL
type	NULL
I.	NULL
EMBO	NULL
J	NULL
.	NULL

5:2883-2888	NULL
.	NULL

Ito	NULL
,	NULL
C.	NULL
Y.	NULL
,	NULL
A.	NULL
G.	NULL
Kazantsev	NULL
,	NULL
and	NULL
A.	NULL
S.	NULL
Baldwin	NULL
,	NULL
Jr.	NULL
1994	NULL
.	NULL

Three	NULL
NF-	NULL
«	NULL
B	NULL
sites	NULL
in	NULL
the	NULL
IxBa	NULL
promoter	NULL
are	NULL
required	NULL
for	NULL
induction	NULL
of	NULL
gene	NULL
expression	NULL
by	NULL
TNFa	NULL
.	NULL

Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

22:3787-3792	NULL
.	NULL

Kanno	NULL
,	NULL
T.	NULL
,	NULL
K.	NULL
Brown	NULL
,	NULL
G.	NULL
Franzoso	NULL
,	NULL
and	NULL
U.	NULL
Siebenlist	NULL
.	NULL

1994	NULL
.	NULL

Kinetic	NULL
analysis	NULL
of	NULL
human	NULL
T-cell	NULL
leukemia	NULL
virus	NULL
type	NULL
I	NULL
Tax-mediated	NULL
activation	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

14:6443-6451	NULL
.	NULL

Kieran	NULL
,	NULL
M.	NULL
,	NULL
V.	NULL
Blank	NULL
,	NULL
F.	NULL
Logeat	NULL
,	NULL
J.	NULL
Vandekerckhove	NULL
,	NULL
F.	NULL
Lottspeich	NULL
,	NULL
O.	NULL
LeBail	NULL
,	NULL
M.	NULL
B	NULL
.	NULL

Urban	NULL
,	NULL
P.	NULL
Kourilsky	NULL
,	NULL
P.	NULL
A.	NULL
Baeuerle	NULL
,	NULL
and	NULL
A.	NULL
Israél	NULL
.	NULL

1990	NULL
.	NULL

The	NULL
DNA	NULL
binding	NULL
subunit	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
is	NULL
identical	NULL
to	NULL
factor	NULL
KBF1	NULL
and	NULL
homologous	NULL
to	NULL
the	NULL
re	NULL
?	NULL

oncogene	NULL
product	NULL
.	NULL

Cell	NULL
62:1007-1018	NULL
.	NULL

Kimata	NULL
,	NULL
J.	NULL
T.	NULL
,	NULL
and	NULL
L.	NULL
Ratner	NULL
.	NULL

1991	NULL
.	NULL

Temporal	NULL
regulation	NULL
of	NULL
viral	NULL
and	NULL
cellular	NULL
gene	NULL
expression	NULL
during	NULL
human	NULL
T-lymphotropic	NULL
virus	NULL
type	NULL
I-mediated	NULL
lym-phocyte	NULL
immortalization	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

65:3134-3141	NULL
.	NULL

Kitajima	NULL
,	NULL
L	NULL
,	NULL
T.	NULL
Shinobara	NULL
,	NULL
J.	NULL
Bilakovics	NULL
,	NULL
D.	NULL
A	NULL
.	NULL

Brown	NULL
,	NULL
X.	NULL
Xu	NULL
,	NULL
and	NULL
M.	NULL
Nerenberg	NULL
.	NULL

1992	NULL
.	NULL

Ablation	NULL
of	NULL
transplanted	NULL
HTLV-1	NULL
Tax-transformed	NULL
tumors	NULL
in	NULL
mice	NULL
by	NULL
antisense	NULL
inhibition	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
.	NULL

Science	NULL
258:1792-1795	NULL
.	NULL

Koeffler	NULL
,	NULL
H.	NULL
P.	NULL
,	NULL
I.	NULL
S.	NULL
Chen	NULL
,	NULL
and	NULL
D.	NULL
W.	NULL
Golde	NULL
.	NULL

1984	NULL
.	NULL

Characterization	NULL
of	NULL
a	NULL
novel	NULL
HTLV-infected	NULL
cell	NULL
line	NULL
.	NULL

Blood	NULL
64:482-490	NULL
.	NULL

2090	NULL
42	NULL
.	NULL

43	NULL
.	NULL

44	NULL
.	NULL

45	NULL
.	NULL

46	NULL
.	NULL

47	NULL
.	NULL

48	NULL
.	NULL

49	NULL
.	NULL

50	NULL
.	NULL

51	NULL
.	NULL

52	NULL
.	NULL

53	NULL
.	NULL

54	NULL
.	NULL

55	NULL
.	NULL

56	NULL
.	NULL

57	NULL
.	NULL

58	NULL
.	NULL

59	NULL
.	NULL

60	NULL
.	NULL

61	NULL
.	NULL

62	NULL
.	NULL

McKINSEY	NULL
ET	NULL
AL	NULL
.	NULL

Lacoste	NULL
,	NULL
J.	NULL
,	NULL
L	NULL
Petropoulos	NULL
,	NULL
N.	NULL
Pépin	NULL
,	NULL
and	NULL
J.	NULL
Hiscott	NULL
.	NULL

1995	NULL
.	NULL

Constitutive	NULL
phosphorylation	NULL
and	NULL
turnover	NULL
of	NULL
IxBa	NULL
in	NULL
human	NULL
T-cell	NULL
leukemia	NULL
virus	NULL
type-1-infected	NULL
and	NULL
Tax-expressing	NULL
T	NULL
cells	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

69:564-569	NULL
.	NULL

Le	NULL
Bail	NULL
,	NULL
O.	NULL
,	NULL
R.	NULL
Schmidt-Ullrich	NULL
,	NULL
and	NULL
A.	NULL
Israel	NULL
.	NULL

1993	NULL
.	NULL

Promoter	NULL
analysis	NULL
of	NULL
the	NULL
gene	NULL
encoding	NULL
the	NULL
IxBa/MAD3	NULL
inhibitor	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
:	NULL
positive	NULL
regulation	NULL
by	NULL
members	NULL
of	NULL
the	NULL
rel/NF-	NULL
«	NULL
B	NULL
family	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

12:5043-5049	NULL
.	NULL

Leung	NULL
,	NULL
K.	NULL
,	NULL
and	NULL
G.	NULL
Nabel	NULL
.	NULL

1988	NULL
.	NULL

HTLV-1	NULL
transactivator	NULL
induces	NULL
interleukin-2	NULL
receptor	NULL
expression	NULL
through	NULL
an	NULL
NF-B-like	NULL
factor	NULL
.	NULL

Nature	NULL
(	NULL
London	NULL
)	NULL
333:776-778	NULL
.	NULL

Maruyama	NULL
,	NULL
M.	NULL
,	NULL
H.	NULL
Shibuya	NULL
,	NULL
H.	NULL
Harada	NULL
,	NULL
M.	NULL
Hatakeyama	NULL
,	NULL
M.	NULL
Seiki	NULL
,	NULL
T.	NULL
Fujita	NULL
,	NULL
J.-I	NULL
.	NULL

Inoue	NULL
,	NULL
M.	NULL
Yoshida	NULL
,	NULL
and	NULL
T.	NULL
Taniguchi	NULL
.	NULL

1987	NULL
.	NULL

Evidence	NULL
for	NULL
aberrant	NULL
activation	NULL
of	NULL
the	NULL
interleukin-2	NULL
autocrine	NULL
loop	NULL
by	NULL
HTLV-I-encoded	NULL
p40*	NULL
and	NULL
T3/Ti	NULL
complex	NULL
triggering	NULL
.	NULL

Cell	NULL
48:343-350	NULL
.	NULL

Meyer	NULL
,	NULL
R.	NULL
,	NULL
E.	NULL
N.	NULL
Hatada	NULL
,	NULL
H.-P.	NULL
Hohmann	NULL
,	NULL
M.	NULL
Haiker	NULL
,	NULL
C.	NULL
Bartsch	NULL
,	NULL
U.	NULL
Roth-lisberger	NULL
,	NULL
H.-W.	NULL
Lahm	NULL
,	NULL
E.	NULL
J.	NULL
Schlaeger	NULL
,	NULL
A.	NULL
P.	NULL
G.	NULL
M.	NULL
van	NULL
Loon	NULL
,	NULL
and	NULL
C.	NULL
Scheidereit	NULL
.	NULL

1991	NULL
.	NULL

Cloning	NULL
of	NULL
the	NULL
DNA-binding	NULL
subunit	NULL
of	NULL
human	NULL
nuclear	NULL
factor	NULL
xB	NULL
:	NULL
the	NULL
level	NULL
of	NULL
its	NULL
mRNA	NULL
is	NULL
strongly	NULL
regulated	NULL
by	NULL
phorbol	NULL
ester	NULL
or	NULL
tumor	NULL
necrosis	NULL
factor	NULL
«	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
88:966-970	NULL
.	NULL

Miyoshi	NULL
,	NULL
I.	NULL
,	NULL
I.	NULL
Kubonishi	NULL
,	NULL
S.	NULL
Yoshimoto	NULL
,	NULL
T.	NULL
Akagi	NULL
,	NULL
Y.	NULL
Ohtsuki	NULL
,	NULL
Y.	NULL
Shiraishi	NULL
,	NULL
K.	NULL
Nagata	NULL
,	NULL
Y.	NULL
Hinuma	NULL
.	NULL

1981	NULL
.	NULL

Type	NULL
C	NULL
virus	NULL
particles	NULL
in	NULL
a	NULL
cord	NULL
T-cell	NULL
line	NULL
derived	NULL
by	NULL
co-cultivating	NULL
normal	NULL
human	NULL
cord	NULL
leukocytes	NULL
and	NULL
human	NULL
leukae-mic	NULL
T	NULL
cells	NULL
.	NULL

Nature	NULL
(	NULL
London	NULL
)	NULL
294:770-771	NULL
.	NULL

Miyoshi	NULL
,	NULL
L	NULL
,	NULL
I.	NULL
Kubonishi	NULL
,	NULL
S.	NULL
Yoshimoto	NULL
,	NULL
and	NULL
Y.	NULL
Shiraishi	NULL
.	NULL

1981	NULL
.	NULL

A	NULL
T-cell	NULL
line	NULL
derived	NULL
from	NULL
normal	NULL
human	NULL
cord	NULL
leukocytes	NULL
by	NULL
co-culturing	NULL
with	NULL
human	NULL
leukemic	NULL
T-cells	NULL
.	NULL

Gann	NULL
72:978-981	NULL
.	NULL

Nakamaye	NULL
,	NULL
K.	NULL
,	NULL
and	NULL
F.	NULL
Eckstein	NULL
.	NULL

1986	NULL
.	NULL

Inhibition	NULL
of	NULL
restriction	NULL
endonuclease	NULL
Nei	NULL
I	NULL
cleavage	NULL
by	NULL
phosphothioate	NULL
groups	NULL
and	NULL
its	NULL
application	NULL
to	NULL
oligonucle-otide-directed	NULL
mutagenesis	NULL
.	NULL

Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

14:9679-9698	NULL
.	NULL

Nerenberg	NULL
,	NULL
M.	NULL
,	NULL
S.	NULL
H.	NULL
Hinrichs	NULL
,	NULL
R.	NULL
K.	NULL
Reynolds	NULL
,	NULL
G.	NULL
Khoury	NULL
,	NULL
and	NULL
G.	NULL
Jay	NULL
.	NULL

1987	NULL
.	NULL

The	NULL
fat	NULL
gene	NULL
of	NULL
human	NULL
T-lymphotropic	NULL
virus	NULL
type	NULL
I	NULL
induces	NULL
mesenchymal	NULL
tumors	NULL
in	NULL
transgenic	NULL
mice	NULL
.	NULL

Science	NULL
237:1324-1329	NULL
.	NULL

Neumann	NULL
,	NULL
J.	NULL
,	NULL
C.	NULL
Morency	NULL
,	NULL
and	NULL
K.	NULL
Russian	NULL
.	NULL

1987	NULL
.	NULL

A	NULL
novel	NULL
rapid	NULL
assay	NULL
for	NULL
chloramphenicol	NULL
acetyltransferase	NULL
gene	NULL
expression	NULL
.	NULL

BioTechniques	NULL
5:444-447	NULL
.	NULL

Nolan	NULL
,	NULL
G.	NULL
P.	NULL
,	NULL
S.	NULL
Ghosh	NULL
,	NULL
H.-C	NULL
.	NULL

Lion	NULL
,	NULL
P.	NULL
Tempst	NULL
,	NULL
and	NULL
D.	NULL
Baltimore	NULL
.	NULL

1991	NULL
.	NULL

DNA	NULL
binding	NULL
and	NULL
IxB	NULL
inhibition	NULL
of	NULL
the	NULL
cloned	NULL
p65	NULL
subunit	NULL
of	NULL
NF-xB	NULL
,	NULL
a	NULL
ref-related	NULL
polypeptide	NULL
.	NULL

Cell	NULL
64:961-969	NULL
.	NULL

Palombella	NULL
,	NULL
V.	NULL
J.	NULL
,	NULL
O.	NULL
J.	NULL
Rando	NULL
,	NULL
A.	NULL
L.	NULL
Goldberg	NULL
,	NULL
and	NULL
'T	NULL
.	NULL

Maniatis	NULL
.	NULL

1994	NULL
.	NULL

Ubiquitin	NULL
and	NULL
the	NULL
proteasome	NULL
are	NULL
required	NULL
for	NULL
processing	NULL
the	NULL
NF-	NULL
«	NULL
B1	NULL
precursor	NULL
and	NULL
the	NULL
activation	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
.	NULL

Cell	NULL
78:773-785	NULL
.	NULL

Poiesz	NULL
,	NULL
B.	NULL
F.	NULL
,	NULL
F.	NULL
W.	NULL
Ruscetti	NULL
,	NULL
A.	NULL
F.	NULL
Gazdar	NULL
,	NULL
P.	NULL
A.	NULL
Bunn	NULL
,	NULL
J.	NULL
D.	NULL
Minna	NULL
,	NULL
and	NULL
R.	NULL
C.	NULL
Gallo	NULL
.	NULL

1980	NULL
.	NULL

Detection	NULL
and	NULL
isolation	NULL
of	NULL
type	NULL
C	NULL
retrovirus	NULL
particles	NULL
from	NULL
fresh	NULL
cultured	NULL
lymphocytes	NULL
of	NULL
a	NULL
patient	NULL
with	NULL
cutaneous	NULL
T-cell	NULL
lymphoma	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
77:7415-7419	NULL
.	NULL

Pozzatti	NULL
,	NULL
R.	NULL
,	NULL
J.	NULL
Vogel	NULL
,	NULL
and	NULL
G.	NULL
Jay	NULL
.	NULL

1990	NULL
.	NULL

The	NULL
human	NULL
T-lymphotropic	NULL
virus	NULL
type	NULL
I	NULL
fax	NULL
gene	NULL
can	NULL
cooperate	NULL
with	NULL
the	NULL
mas	NULL
oncogene	NULL
to	NULL
induce	NULL
neoplastic	NULL
transformation	NULL
of	NULL
cells	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

10:413-417	NULL
.	NULL

Prickett	NULL
,	NULL
K.	NULL
S.	NULL
,	NULL
D.	NULL
C.	NULL
Amberg	NULL
,	NULL
and	NULL
T.	NULL
P.	NULL
Hopp	NULL
.	NULL

1989	NULL
.	NULL

A	NULL
calcium-dependent	NULL
antibody	NULL
for	NULL
identification	NULL
and	NULL
purification	NULL
of	NULL
recombinant	NULL
proteins	NULL
.	NULL

BioTechniques	NULL
7:580-589	NULL
.	NULL

Ruben	NULL
,	NULL
S.	NULL
M.	NULL
,	NULL
P.	NULL
J.	NULL
Dillon	NULL
,	NULL
R.	NULL
Schreck	NULL
,	NULL
T.	NULL
Henkel	NULL
,	NULL
C.-H.	NULL
Chen	NULL
,	NULL
M.	NULL
Maher	NULL
,	NULL
P.	NULL
A.	NULL
Baeuerle	NULL
,	NULL
and	NULL
C.	NULL
A.	NULL
Rosen	NULL
.	NULL

1991	NULL
.	NULL

Isolation	NULL
of	NULL
a	NULL
ref-related	NULL
human	NULL
cDNA	NULL
that	NULL
potentially	NULL
encodes	NULL
the	NULL
p6S-kD	NULL
subunit	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
.	NULL

Science	NULL
251:1490-1493	NULL
.	NULL

Ruben	NULL
,	NULL
S.	NULL
M.	NULL
,	NULL
R.	NULL
Narayanan	NULL
,	NULL
J.	NULL
F.	NULL
Klement	NULL
,	NULL
C.-H.	NULL
Chen	NULL
,	NULL
and	NULL
C.	NULL
A.	NULL
Rosen	NULL
.	NULL

1992	NULL
.	NULL

Functional	NULL
characterization	NULL
of	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
p65	NULL
transcriptional	NULL
activator	NULL
and	NULL
an	NULL
alternatively	NULL
spliced	NULL
derivative	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

12:444-454	NULL
.	NULL

Ruben	NULL
,	NULL
S.	NULL
M.	NULL
,	NULL
H.	NULL
Poteat	NULL
,	NULL
T.	NULL
H.	NULL
Tan	NULL
,	NULL
K.	NULL
Kawakami	NULL
,	NULL
R.	NULL
Roeder	NULL
,	NULL
W.	NULL
Haseltine	NULL
,	NULL
and	NULL
C.	NULL
A.	NULL
Rosen	NULL
.	NULL

1988	NULL
.	NULL

Cellular	NULL
transcription	NULL
factors	NULL
and	NULL
regulation	NULL
of	NULL
IL-2	NULL
receptor	NULL
gene	NULL
expression	NULL
by	NULL
HTLV-1	NULL
tax	NULL
gene	NULL
product	NULL
.	NULL

Science	NULL
241:89-92	NULL
.	NULL

Salahuddin	NULL
,	NULL
S.	NULL
Z.	NULL
,	NULL
P.	NULL
D.	NULL
Markham	NULL
,	NULL
F.	NULL
Wong-Staal	NULL
,	NULL
G.	NULL
Franchini	NULL
,	NULL
V.	NULL
S.	NULL
Kalyanaraman	NULL
,	NULL
and	NULL
R.	NULL
C.	NULL
Gallo	NULL
.	NULL

1983	NULL
.	NULL

Restricted	NULL
expression	NULL
of	NULL
human	NULL
T-cell	NULL
leukemia-lymphoma	NULL
virus	NULL
(	NULL
HTLV	NULL
)	NULL
in	NULL
transformed	NULL
human	NULL
umbilical	NULL
cord	NULL
blood	NULL
lymphocytes	NULL
.	NULL

Virology	NULL
129:51-64	NULL
.	NULL

Scheffner	NULL
,	NULL
M.	NULL
,	NULL
B	NULL
.	NULL

A.	NULL
Werness	NULL
,	NULL
J.	NULL
M.	NULL
Huibregste	NULL
,	NULL
A.	NULL
J.	NULL
Levine	NULL
,	NULL
and	NULL
P.	NULL
M.	NULL
Howley	NULL
.	NULL

1990	NULL
.	NULL

The	NULL
E6	NULL
oncoprotein	NULL
encoded	NULL
by	NULL
human	NULL
papillomavirus	NULL
types	NULL
16	NULL
and	NULL
18	NULL
promotes	NULL
the	NULL
degradation	NULL
of	NULL
p53	NULL
.	NULL

Cell	NULL
63:1129-1136	NULL
.	NULL

Scherer	NULL
,	NULL
D.	NULL
C.	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
Brockman	NULL
,	NULL
Z.	NULL
Chen	NULL
,	NULL
T.	NULL
Maniatis	NULL
,	NULL
and	NULL
D.	NULL
W.	NULL
Ballard	NULL
.	NULL

1995	NULL
.	NULL

Signal-induced	NULL
degradation	NULL
of	NULL
IxBa	NULL
requires	NULL
site-specific	NULL
ubiquitina-tion	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
92:11259-11263	NULL
.	NULL

63	NULL
.	NULL

64	NULL
.	NULL

65	NULL
.	NULL

66	NULL
.	NULL

67	NULL
.	NULL

68	NULL
.	NULL

69	NULL
.	NULL

70	NULL
.	NULL

71	NULL
.	NULL

72	NULL
.	NULL

73	NULL
.	NULL

74	NULL
.	NULL

75	NULL
.	NULL

76	NULL
.	NULL

77	NULL
.	NULL

78	NULL
.	NULL

79	NULL
.	NULL

80	NULL
.	NULL

81	NULL
.	NULL

82	NULL
.	NULL

Mor	NULL
.	NULL

CELL	NULL
.	NULL

BioL	NULL
.	NULL

Schmitz	NULL
,	NULL
M.	NULL
L.	NULL
,	NULL
and	NULL
P.	NULL
A.	NULL
Baeverle	NULL
.	NULL

1991	NULL
.	NULL

The	NULL
p65	NULL
subunit	NULL
is	NULL
responsible	NULL
for	NULL
the	NULL
strong	NULL
transcription	NULL
activating	NULL
potential	NULL
of	NULL
NF-kB	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

10:3805-3817	NULL
.	NULL

Schreck	NULL
,	NULL
R.	NULL
,	NULL
R.	NULL
Gr	NULL
B.	NULL
Fleckenstein	NULL
,	NULL
and	NULL
P.	NULL
A	NULL
.	NULL

B	NULL
le	NULL
.	NULL

1992	NULL
.	NULL

Anti-oxidants	NULL
selectively	NULL
suppress	NULL
activation	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
by	NULL
human	NULL
T-cell	NULL
leukemia	NULL
virus	NULL
type	NULL
I	NULL
Tax	NULL
protein	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

66:6288-6293	NULL
.	NULL

Schreck	NULL
,	NULL
R.	NULL
,	NULL
P.	NULL
Rieber	NULL
,	NULL
and	NULL
P.	NULL
A.	NULL
Baeuerle	NULL
.	NULL

1991	NULL
.	NULL

Reactive	NULL
oxygen	NULL
intermediates	NULL
as	NULL
apparently	NULL
widely	NULL
used	NULL
messengers	NULL
in	NULL
the	NULL
activation	NULL
of	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
transcription	NULL
factor	NULL
and	NULL
HIV-1	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

10:2247-2258	NULL
.	NULL

Schreiber	NULL
,	NULL
E.	NULL
,	NULL
P.	NULL
Matthias	NULL
,	NULL
M.	NULL
Muller	NULL
,	NULL
and	NULL
W.	NULL
Schaffner	NULL
.	NULL

1989	NULL
.	NULL

Rapid	NULL
detection	NULL
of	NULL
octamer	NULL
binding	NULL
proteins	NULL
with	NULL
'mini-extracts	NULL
'	NULL
,	NULL
prepared	NULL
from	NULL
a	NULL
small	NULL
number	NULL
of	NULL
cells	NULL
.	NULL

Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

17:6419	NULL
.	NULL

Siekevitz	NULL
,	NULL
M.	NULL
,	NULL
M.	NULL
B.	NULL
Feinberg	NULL
,	NULL
N.	NULL
Holbrook	NULL
,	NULL
F.	NULL
Wong-Staal	NULL
,	NULL
and	NULL
W.	NULL
C.	NULL
Greene	NULL
.	NULL

1987	NULL
.	NULL

Activation	NULL
of	NULL
interleukin	NULL
2	NULL
and	NULL
interleukin	NULL
2	NULL
receptor	NULL
(	NULL
Tac	NULL
)	NULL
promoter	NULL
expression	NULL
by	NULL
the	NULL
transactivator	NULL
(	NULL
tat	NULL
)	NULL
gene	NULL
product	NULL
of	NULL
human	NULL
T-cell	NULL
leukemia	NULL
virus	NULL
type	NULL
I.	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
84:5389-5393	NULL
.	NULL

Smith	NULL
,	NULL
M.	NULL
R.	NULL
,	NULL
and	NULL
W.	NULL
C.	NULL
Greene	NULL
.	NULL

1990	NULL
.	NULL

Identification	NULL
of	NULL
HTLV-1	NULL
fax	NULL
transactivator	NULL
mutants	NULL
exhibiting	NULL
novel	NULL
transcriptional	NULL
phenotypes	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

4:1875-1885	NULL
.	NULL

Smith	NULL
,	NULL
M.	NULL
R.	NULL
,	NULL
and	NULL
W.	NULL
C.	NULL
Greene	NULL
.	NULL

1991	NULL
.	NULL

Type	NULL
I	NULL
human	NULL
T-cell	NULL
leukemia	NULL
virus	NULL
Tax	NULL
protein	NULL
transforms	NULL
rat	NULL
fibroblasts	NULL
through	NULL
the	NULL
cyclic	NULL
adenosine	NULL
mono-phosphate	NULL
response	NULL
element	NULL
binding	NULL
protein/activating	NULL
transcription	NULL
factor	NULL
pathway	NULL
.	NULL

J.	NULL
Clin	NULL
.	NULL

Invest	NULL
.	NULL

88:1038-1042	NULL
.	NULL

Sodroski	NULL
,	NULL
J.	NULL
,	NULL
C.	NULL
Rosen	NULL
,	NULL
W.	NULL
C.	NULL
Gob	NULL
,	NULL
and	NULL
W.	NULL
Haseltine	NULL
.	NULL

1985	NULL
.	NULL

A	NULL
transcriptional	NULL
activator	NULL
protein	NULL
encoded	NULL
by	NULL
the	NULL
x-lor	NULL
region	NULL
of	NULL
human	NULL
T	NULL
cell	NULL
leukemia	NULL
virus	NULL
.	NULL

Science	NULL
228:1430-1434	NULL
.	NULL

Stein	NULL
,	NULL
B.	NULL
,	NULL
H.	NULL
Rahmsdorf	NULL
,	NULL
A.	NULL
Steffen	NULL
,	NULL
M.	NULL
Litfin	NULL
,	NULL
and	NULL
P.	NULL
Herrlich	NULL
.	NULL

1989	NULL
.	NULL

UV-induced	NULL
DNA	NULL
damage	NULL
is	NULL
an	NULL
intermediate	NULL
step	NULL
in	NULL
UV-induced	NULL
expression	NULL
of	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
type	NULL
1	NULL
,	NULL
collagenase	NULL
,	NULL
c-fos	NULL
,	NULL
and	NULL
metallothio-nein	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

95169-5181	NULL
.	NULL

Sun	NULL
,	NULL
S.-C.	NULL
,	NULL
J.	NULL
Elwood	NULL
,	NULL
C.	NULL
Béraud	NULL
,	NULL
and	NULL
W.	NULL
C.	NULL
Greene	NULL
.	NULL

1994	NULL
.	NULL

Human	NULL
T-cell	NULL
leukemia	NULL
virus	NULL
type	NULL
I	NULL
Tax	NULL
activation	NULL
of	NULL
NF-xB/Rel	NULL
involves	NULL
phosphorylation	NULL
and	NULL
degradation	NULL
of	NULL
IxBa	NULL
and	NULL
RelA	NULL
(	NULL
p65	NULL
)	NULL
-mediated	NULL
induction	NULL
of	NULL
the	NULL
cel	NULL
gene	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

14:7377-7384	NULL
.	NULL

Sun	NULL
,	NULL
S.-C.	NULL
,	NULL
P.	NULL
Ganchi	NULL
,	NULL
D.	NULL
W.	NULL
Ballard	NULL
,	NULL
and	NULL
W.	NULL
C.	NULL
Greene	NULL
.	NULL

1993	NULL
.	NULL

NF-kB	NULL
controls	NULL
expression	NULL
of	NULL
inhibitor	NULL
IxBa	NULL
:	NULL
evidence	NULL
for	NULL
an	NULL
inducible	NULL
autoregulatory	NULL
pathway	NULL
.	NULL

Science	NULL
259:1912-1915	NULL
.	NULL

Suzuki	NULL
,	NULL
T.	NULL
,	NULL
H.	NULL
Hirai	NULL
,	NULL
T.	NULL
Murakami	NULL
,	NULL
and	NULL
M.	NULL
Yoshida	NULL
.	NULL

1995	NULL
.	NULL

Tax	NULL
protein	NULL
of	NULL
HTLV-1	NULL
destabilizes	NULL
the	NULL
complexes	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
and	NULL
and	NULL
induces	NULL
nuclear	NULL
translocation	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
for	NULL
transcriptional	NULL
activation	NULL
.	NULL

Oncogene	NULL
10:1199-1207	NULL
.	NULL

Tanaka	NULL
,	NULL
A.	NULL
,	NULL
C.	NULL
Takahashi	NULL
,	NULL
S.	NULL
Yamaoka	NULL
,	NULL
T.	NULL
Nosaka	NULL
,	NULL
M.	NULL
Maki	NULL
,	NULL
and	NULL
M.	NULL
Ha-tanaka	NULL
.	NULL

1990	NULL
.	NULL

Oncogenic	NULL
transformation	NULL
by	NULL
the	NULL
tex	NULL
gene	NULL
of	NULL
human	NULL
T-cell	NULL
leukemia	NULL
virus	NULL
type	NULL
I	NULL
in	NULL
vitro	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
87:1071-1075	NULL
.	NULL

Ten	NULL
,	NULL
R.	NULL
M.	NULL
,	NULL
C.	NULL
V.	NULL
Paya	NULL
,	NULL
N.	NULL
Israel	NULL
,	NULL
O.	NULL
LeBail	NULL
,	NULL
M.	NULL
G.	NULL
Mattei	NULL
,	NULL
J.	NULL
L.	NULL
Virelizier	NULL
,	NULL
P.	NULL
Kourilsky	NULL
,	NULL
and	NULL
A.	NULL
Israél	NULL
.	NULL

1992	NULL
.	NULL

The	NULL
characterization	NULL
of	NULL
the	NULL
promoter	NULL
of	NULL
the	NULL
gene	NULL
encoding	NULL
the	NULL
p50	NULL
subunit	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
indicates	NULL
that	NULL
it	NULL
participates	NULL
in	NULL
its	NULL
own	NULL
regulation	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

11:195-203	NULL
.	NULL

Thompson	NULL
,	NULL
J.	NULL
E.	NULL
,	NULL
R.	NULL
J.	NULL
Phillips	NULL
,	NULL
H.	NULL
Erdjument-Bromage	NULL
,	NULL
P.	NULL
Tempst	NULL
,	NULL
and	NULL
S.	NULL
Ghosh	NULL
.	NULL

1995	NULL
.	NULL

IxB-B	NULL
regulates	NULL
the	NULL
persistent	NULL
response	NULL
in	NULL
a	NULL
biphasic	NULL
activation	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
.	NULL

Cell	NULL
80:573-582	NULL
.	NULL

Traenckner	NULL
,	NULL
E.	NULL
B.-M.	NULL
,	NULL
H.	NULL
L.	NULL
Pahl	NULL
,	NULL
T.	NULL
Henkel	NULL
,	NULL
K.	NULL
N.	NULL
Schmidt	NULL
,	NULL
S.	NULL
Wilk	NULL
,	NULL
and	NULL
P.	NULL
A.	NULL
Baeuerle	NULL
.	NULL

1995	NULL
.	NULL

Phosphorylation	NULL
of	NULL
human	NULL
IxB-	NULL
«	NULL
on	NULL
serines	NULL
32	NULL
and	NULL
36	NULL
controls	NULL
IxB-	NULL
«	NULL
proteolysis	NULL
and	NULL
NF-kB	NULL
activation	NULL
in	NULL
response	NULL
to	NULL
diverse	NULL
stimuli	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

14:2876-2883	NULL
.	NULL

Traenckner	NULL
,	NULL
E	NULL
.	NULL

BM	NULL
.	NULL

,	NULL
S.	NULL
Wilk	NULL
,	NULL
and	NULL
P.	NULL
A.	NULL
Baeuerle	NULL
.	NULL

1994	NULL
.	NULL

A	NULL
proteasome	NULL
inhibitor	NULL
prevents	NULL
activation	NULL
of	NULL
NF-xB	NULL
and	NULL
stabilizes	NULL
a	NULL
newly	NULL
phosphorylated	NULL
form	NULL
of	NULL
IxBa	NULL
that	NULL
is	NULL
still	NULL
bound	NULL
to	NULL
NF-	NULL
«	NULL
B	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

13:5433-5441	NULL
.	NULL

Treier	NULL
,	NULL
M.	NULL
,	NULL
L.	NULL
M.	NULL
Staszewski	NULL
,	NULL
and	NULL
D.	NULL
Bohmann	NULL
.	NULL

1994	NULL
.	NULL

Ubiquitin-dependent	NULL
c-Jun	NULL
degradation	NULL
in	NULL
vivo	NULL
is	NULL
mediated	NULL
by	NULL
the	NULL
8	NULL
domain	NULL
.	NULL

Cell	NULL
78:787-798	NULL
.	NULL

Watanabe	NULL
,	NULL
M.	NULL
,	NULL
M.-A	NULL
.	NULL

Muramatsu	NULL
,	NULL
H.	NULL
Hirai	NULL
,	NULL
T.	NULL
Suzuki	NULL
,	NULL
J.	NULL
Fujisawa	NULL
,	NULL
M.	NULL
Yoshida	NULL
,	NULL
K.-L.	NULL
Arai	NULL
,	NULL
and	NULL
N.	NULL
Arai	NULL
.	NULL

1993	NULL
.	NULL

HTLV-I	NULL
encoded	NULL
Tax	NULL
in	NULL
association	NULL
with	NULL
NF-kB	NULL
precursor	NULL
p105	NULL
enhances	NULL
nuclear	NULL
localization	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
p50	NULL
and	NULL
p65	NULL
in	NULL
transfected	NULL
cells	NULL
.	NULL

Oncogene	NULL
8:2949-2958	NULL
.	NULL

Yoshida	NULL
,	NULL
M.	NULL
,	NULL
I.	NULL
Miyoshi	NULL
,	NULL
and	NULL
Y.	NULL
Hinuma	NULL
.	NULL

1982	NULL
.	NULL

Isolation	NULL
and	NULL
characterization	NULL
of	NULL
retrovirus	NULL
from	NULL
cell	NULL
lines	NULL
of	NULL
human	NULL
adult	NULL
T-cell	NULL
leukemia	NULL
and	NULL
its	NULL
implication	NULL
in	NULL
the	NULL
disease	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
79:2031-2035	NULL
.	NULL

